Jump to content
RemedySpot.com

Re: Anabolic steroids- where are the bodies.

Rate this topic


Recommended Posts

Posted

A common refrain amongst apologists for anabolic steroids is : Where are the

bodies? The bodies are in the cemetary ony the death certificated does not

state they died from steroids. The most likely cause of death heart disease.

It might be cardiac arrhythmia or acute MI.

There is an excellent article in the American Journal of Cardiology which

reviews A total of 49 studies describing 1,467 athletes were reviewed to

investigate the cardiovascular effects of the abuse of AAS.

It cites 99 articles covering this topic. If you are interested in this topic

go to your local hospital Library and check out :

Cardiac and Metabolic Effects of Anabolic-Androgenic Steroid Abuse on Lipids,

Blood Pressure, Left Ventricular Dimensions, and

Rhythm

The American Journal of Cardiology - Volume 106, Issue 6 (September 2010) -

Copyright © 2010 The American College of Cardiology -

Because of copyright and space I cannot put the article here but I have taken

the time to excerpt some of the information I thought might be pertinent along

with the articles or journals cited.

You are not likely to find these studies in your typical muscle magazine or

website. Some of these studies date back to the mid 80s and 90s. The

information is not new just conveniently ignored.

***********************

Cardiac and Metabolic Effects of Anabolic-Androgenic Steroid Abuse on Lipids,

Blood Pressure, Left Ventricular Dimensions, and Rhythm

The American Journal of Cardiology - Volume 106, Issue 6 (September 2010) -

Copyright © 2010 The American College of Cardiology -

AAS and abnormal plasma lipoproteins

AAS abuse has been linked with abnormal plasma lipoproteins (Table 1). Several

studies suggest that AAS abuse in athletes increase low-density lipoprotein

(LDL)

levels by >20% [14] , [36] , [37] , [38] and decrease high-density lipoprotein

(HDL) levels by 20% to 70%. [13] , [14] , [37] , [39] , [40] , [41] , [42] ,

[43] , [44]

By some estimates, these lipoprotein abnormalities increase

the risk for coronary artery disease by three- to sixfold. [14] , [45]

13 Sader M.A., Griffiths K.A., McCredie R.J., Handelsman D.J., Celermajer

D.S.: Androgenic anabolic steroids and arterial structure and function in male

bodybuilders. J Am Coll Cardiol 37. 224-230.2001; Abstract

14 Lenders J.W., Demacker P.N., Vos J.A., Jansen P.L., Hoitsma A.J., Van't Laar

A., Thien T.: Deleterious effects of anabolic steroids on serum lipoproteins,

blood

pressure, and liver function in amateur bodybuilders. Int J Sports Med 9.

19-23.1988; Abstrac

36 Lajarin F., Zaragoza R., r I., ez- P.: Evolution of

serum lipids in two male bodybuilders using anabolic steroids. Clin Chem 42.

970-

972.1996; Abstract

37 McKillop G., Ballantyne D.: Lipoprotein analysis in bodybuilders. Int J

Cardiol 17. 281-288.1987; Abstract

38 Palatini P., Giada F., Garavelli G., Sinisi F., L., Michieletto M.,

Baldo-Enzi G.: Cardiovascular effects of anabolic steroids in weight-trained

subjects. J Clin

Pharmacol 36. 1132-1140.1996; Abstract

39 Baldo-Enzi G., Giada F., Zuliani G., Baroni L., Vitale E., Enzi G.,

Magnanini P., Fellin R.: Lipid and apoprotein modifications in body builders

during and after self-

administration of anabolic steroids. Metabolism 39. 203-208.1990; Abstract

40 Fröhlich J., Kullmer T., Urhausen A., Bergmann R., Kindermann W.: Lipid

profile of body builders with and without self-administration of anabolic

steroids. Eur J

Appl Physiol 59. 98-103.1989; 41 Hartgens F., Rietjens G., K

41 Hartgens F., Rietjens G., Keizer H.A., Kuipers H., Wolffenbuttel B.:

Effects of androgenic-anabolic steroids on apolipoproteins and lipoprotein (a).

Br J Sport

Med 38. 253-259.2004;

42 Lane H., Grace F., J.C., K., Cockcroft J., Scanlon M.F., Davies

J.S.: Impaired vasoreactivity in bodybuilders using androgenic anabolic

steroids. Eur J

Clin Invest 36. 483-488.2006; Abstract

43 Urhausen A., Albers T., Kindermann W.: Are the cardiac effects of anabolic

steroid abuse in strength athletes reversible?. Heart 90. 496-501.2004;

Abstract

44 Zuliani U., Bernardini B., Catapano A., Campana M., Cerioli G., Spattini

M.: Effects of anabolic steroids, testosterone, and HGH on blood lipids and

echocardiographic parameteres in body builders. Int J Sports Med 10.

62-66.1989; Abstract

45 Glazer G.: Atherogenic effects of anabolic steroids on serum lipid levels.

A literature reviewArch Intern Med 151. 1925-1933.1991; Abstract

AAS, acute MI, and sudden death

Alarming data have linked AAS with fatal events, although these are mostly

case-control studies and case reports of acute coronary syndromes, MIs, and

ventricular

arrhythmias. [24] , [46] , [83] , [84] , [85] , [86] , [87] , [88]

88 Fineschi V., Riezzo I., Centini F., Silingardi E., Licata M., Beduschi G.,

Karch S.B.: Sudden cardiac death during anabolic steroid abuse: morphologic and

toxicologic findings in two fatal cases of bodybuilders. Int J Legal Med 121.

48-53.2007; Abstract

89 Sullivan M.L., ez C.M., Gennis P., Gallagher E.J.: The cardiac

toxicity of anabolic steroids. Prog Cardiovasc Dis 41. 1-15.1998; Abstract

90 Ferenchick G.: Anabolic/androgenic steroid abuse and thrombosis: is there a

connection?. Med Hypotheses 35. 27-31.1991; Abstract

91 Roeggia M., Heinz G., Werba E., Roeggla G.: Cardiac tamponade in a

21-year-old body builder with anabolica abuse. Br J Clin Pract 50.

411-412.1996; Citation

92 Ferenchick G., Adelman S.: Myocardial infarction associated with anabolic

steroid use in a previously healthy 37-year-old weight lifter. Am Heart J 124.

507-

508.1992; Citation

93 Huie M.: An acute myocardial infarction occurring in an anabolic steroid

user. Med Sci Sport Exer 26. 408-413.1994;

94 Fisher M., Appleby M., Rittoo D., Cotter L.: Myocardial infarction with

extensive intracoronary thrombus induced by anabolic steroids. Br J Clin Pract

50. 222-

223.1996; Abstract

a postmortem study of male Caucasian AAS abusers (aged 20 to 45 years) suggested

primary cardiac pathology in 1/3, [23]

23 Thiblin I., Lindquist O., Rajs J.: Cause and manner of death among users of

anabolic androgenic steroids. J Forensic Sci 45. 16-23.2000; Abstract

recent case-control study [24] , [25] suggested cardiac causes in 2/3 of deaths,

with others being attributed to suicide, hepatic coma, and malignancy.

24 Parssinen M., Kujala U., Vartiainen E., Sarna S., Seppala T.: Increased

premature mortality of competitive powerlifters suspected to have used anabolic

agents. Int J Sports Med 21. 225-227.2000; Abstrac

25 Parssinen M., Seppala T.: Steroid use and long-term health risks in former

athletes. Sports Med 2002. 83-84.2002; 2

Hausmann et al [84] describe a 23-year-old male bodybuilder who abused AAS and

experienced sudden cardiac arrest. Postmortem examination revealed ventricular

hypertrophy, myocardial fibrosis, and acute MI, and the cause of death was

attributed to arrhythmic sudden death secondary to AAS abuse.

84 Hausmann R., Hammer S., Betz P.: Performance enhancing drugs (doping agents)

and sudden death—a case report and review of the literature. Int J Legal Med

111. 261-264.1998; Abstrac

McNutt et al[46] reported an acute MI in a 22-year-old bodybuilder who admitted

to AAS abuse but lacked cardiac risk factors. The patient presented with

markedly elevated LDL (596 mg/dl) and depressed HDL (14 mg/dl) yet had no family

history of premature atherosclerosis or cardiac events. Within a month of

discontinuing AAS, his LDL decreased to 220 mg/dl and his HDL increased to 35

mg/dl.

46 McNutt R.A., Ferenchick G.S., Kirlin P.C., Hamlin N.J.: Acute myocardial

infarction in a 22-year-old world class weight lifter using anabolic steroids.

Am J Cardiol62.164.1988; Citation

49 Bowman S.: Anabolic steroids and infarction. BMJ 300. 750.1990; Citation

Figure 1 shows the presenting electrocardiogram of a 25-year-old male athlete

who abused nandrolone and presented with an acute MI without traditional cardiac

risk factors. Acute angiography revealed extensive left anterior descending

coronary artery thrombosis, which was managed by thrombolysis. Angiography in

the subacute phase confirmed very mild luminal irregularity at the site of

previous thrombosis.

69 Kennedy C.: Myocardial infarction in association with misuse of anabolic

steroids. Ulster Med J 62. 174-176.1993; Citation

The most commonly observed arrhythmias, typically occurring during physical

exertion, include atrial fibrillation, ventricular fibrillation, ventricular

tachycardia, and supraventricular and ventricular ectopic beats. [95]

95 Furlanello F., Serdoz L.V., Cappato R., De Ambroggi L.: Illicit drugs and

cardiac arrhythmias in athletes. Eur J Cardiovasc Prev Rehabil 14. 487-494.2007;

Abstract

Dickerman et al [96] reported a 20-year-old male bodybuilder who

self-administered AAS 700 mg/week and had sudden cardiac arrest. Autopsy

indicated LVH with a cardiac mass >2 times the upper limit of normal.

96 Dickerman R.D., Schaller F., Prather I., McConathy W.J.: Sudden cardiac death

in a 20-year-old bodybuilder using anabolic steroids. Cardiology 86.

172-173.1995; Abstract

******************

Ralph Giarnella MD

Southington Ct. USA

Posted

You forgot about cancer. I know athletes that used AAS and ended up getting

cancer.

Edwin Freeman, Jr.

San Francisco, CA

Re: Anabolic steroids- where are the bodies.

A common refrain amongst apologists for anabolic steroids is : Where are the

bodies? The bodies are in the cemetary ony the death certificated does not

state they died from steroids. The most likely cause of death heart disease.

It might be cardiac arrhythmia or acute MI.

There is an excellent article in the American Journal of Cardiology which

reviews A total of 49 studies describing 1,467 athletes were reviewed to

investigate the cardiovascular effects of the abuse of AAS.

It cites 99 articles covering this topic. If you are interested in this topic

go to your local hospital Library and check out :

Cardiac and Metabolic Effects of Anabolic-Androgenic Steroid Abuse on Lipids,

Blood Pressure, Left Ventricular Dimensions, and

Rhythm

The American Journal of Cardiology - Volume 106, Issue 6 (September 2010) -

Copyright © 2010 The American College of Cardiology -

Because of copyright and space I cannot put the article here but I have taken

the time to excerpt some of the information I thought might be pertinent along

with the articles or journals cited.

You are not likely to find these studies in your typical muscle magazine or

website. Some of these studies date back to the mid 80s and 90s. The

information is not new just conveniently ignored.

***********************

Cardiac and Metabolic Effects of Anabolic-Androgenic Steroid Abuse on Lipids,

Blood Pressure, Left Ventricular Dimensions, and Rhythm

The American Journal of Cardiology - Volume 106, Issue 6 (September 2010) -

Copyright © 2010 The American College of Cardiology -

AAS and abnormal plasma lipoproteins

AAS abuse has been linked with abnormal plasma lipoproteins (Table 1). Several

studies suggest that AAS abuse in athletes increase low-density lipoprotein

(LDL)

levels by >20% [14] , [36] , [37] , [38] and decrease high-density lipoprotein

(HDL) levels by 20% to 70%. [13] , [14] , [37] , [39] , [40] , [41] , [42] ,

[43] , [44]

By some estimates, these lipoprotein abnormalities increase

the risk for coronary artery disease by three- to sixfold. [14] , [45]

13 Sader M.A., Griffiths K.A., McCredie R.J., Handelsman D.J., Celermajer

D.S.: Androgenic anabolic steroids and arterial structure and function in male

bodybuilders. J Am Coll Cardiol 37. 224-230.2001; Abstract

14 Lenders J.W., Demacker P.N., Vos J.A., Jansen P.L., Hoitsma A.J., Van't Laar

A., Thien T.: Deleterious effects of anabolic steroids on serum lipoproteins,

blood

pressure, and liver function in amateur bodybuilders. Int J Sports Med 9.

19-23.1988; Abstrac

36 Lajarin F., Zaragoza R., r I., ez- P.: Evolution of

serum lipids in two male bodybuilders using anabolic steroids. Clin Chem 42.

970-

972.1996; Abstract

37 McKillop G., Ballantyne D.: Lipoprotein analysis in bodybuilders. Int J

Cardiol 17. 281-288.1987; Abstract

38 Palatini P., Giada F., Garavelli G., Sinisi F., L., Michieletto M.,

Baldo-Enzi G.: Cardiovascular effects of anabolic steroids in weight-trained

subjects. J Clin

Pharmacol 36. 1132-1140.1996; Abstract

39 Baldo-Enzi G., Giada F., Zuliani G., Baroni L., Vitale E., Enzi G.,

Magnanini P., Fellin R.: Lipid and apoprotein modifications in body builders

during and after self-

administration of anabolic steroids. Metabolism 39. 203-208.1990; Abstract

40 Fröhlich J., Kullmer T., Urhausen A., Bergmann R., Kindermann W.: Lipid

profile of body builders with and without self-administration of anabolic

steroids. Eur J

Appl Physiol 59. 98-103.1989; 41 Hartgens F., Rietjens G., K

41 Hartgens F., Rietjens G., Keizer H.A., Kuipers H., Wolffenbuttel B.:

Effects of androgenic-anabolic steroids on apolipoproteins and lipoprotein (a).

Br J Sport

Med 38. 253-259.2004;

42 Lane H., Grace F., J.C., K., Cockcroft J., Scanlon M.F., Davies

J.S.: Impaired vasoreactivity in bodybuilders using androgenic anabolic

steroids. Eur J

Clin Invest 36. 483-488.2006; Abstract

43 Urhausen A., Albers T., Kindermann W.: Are the cardiac effects of anabolic

steroid abuse in strength athletes reversible?. Heart 90. 496-501.2004;

Abstract

44 Zuliani U., Bernardini B., Catapano A., Campana M., Cerioli G., Spattini

M.: Effects of anabolic steroids, testosterone, and HGH on blood lipids and

echocardiographic parameteres in body builders. Int J Sports Med 10.

62-66.1989; Abstract

45 Glazer G.: Atherogenic effects of anabolic steroids on serum lipid levels.

A literature reviewArch Intern Med 151. 1925-1933.1991; Abstract

AAS, acute MI, and sudden death

Alarming data have linked AAS with fatal events, although these are mostly

case-control studies and case reports of acute coronary syndromes, MIs, and

ventricular

arrhythmias. [24] , [46] , [83] , [84] , [85] , [86] , [87] , [88]

88 Fineschi V., Riezzo I., Centini F., Silingardi E., Licata M., Beduschi G.,

Karch S.B.: Sudden cardiac death during anabolic steroid abuse: morphologic and

toxicologic findings in two fatal cases of bodybuilders. Int J Legal Med 121.

48-53.2007; Abstract

89 Sullivan M.L., ez C.M., Gennis P., Gallagher E.J.: The cardiac

toxicity of anabolic steroids. Prog Cardiovasc Dis 41. 1-15.1998; Abstract

90 Ferenchick G.: Anabolic/androgenic steroid abuse and thrombosis: is there a

connection?. Med Hypotheses 35. 27-31.1991; Abstract

91 Roeggia M., Heinz G., Werba E., Roeggla G.: Cardiac tamponade in a

21-year-old body builder with anabolica abuse. Br J Clin Pract 50.

411-412.1996; Citation

92 Ferenchick G., Adelman S.: Myocardial infarction associated with anabolic

steroid use in a previously healthy 37-year-old weight lifter. Am Heart J 124.

507-

508.1992; Citation

93 Huie M.: An acute myocardial infarction occurring in an anabolic steroid

user. Med Sci Sport Exer 26. 408-413.1994;

94 Fisher M., Appleby M., Rittoo D., Cotter L.: Myocardial infarction with

extensive intracoronary thrombus induced by anabolic steroids. Br J Clin Pract

50. 222-

223.1996; Abstract

a postmortem study of male Caucasian AAS abusers (aged 20 to 45 years) suggested

primary cardiac pathology in 1/3, [23]

23 Thiblin I., Lindquist O., Rajs J.: Cause and manner of death among users of

anabolic androgenic steroids. J Forensic Sci 45. 16-23.2000; Abstract

recent case-control study [24] , [25] suggested cardiac causes in 2/3 of deaths,

with others being attributed to suicide, hepatic coma, and malignancy.

24 Parssinen M., Kujala U., Vartiainen E., Sarna S., Seppala T.: Increased

premature mortality of competitive powerlifters suspected to have used anabolic

agents. Int J Sports Med 21. 225-227.2000; Abstrac

25 Parssinen M., Seppala T.: Steroid use and long-term health risks in former

athletes. Sports Med 2002. 83-84.2002; 2

Hausmann et al [84] describe a 23-year-old male bodybuilder who abused AAS and

experienced sudden cardiac arrest. Postmortem examination revealed ventricular

hypertrophy, myocardial fibrosis, and acute MI, and the cause of death was

attributed to arrhythmic sudden death secondary to AAS abuse.

84 Hausmann R., Hammer S., Betz P.: Performance enhancing drugs (doping agents)

and sudden death—a case report and review of the literature. Int J Legal Med

111. 261-264.1998; Abstrac

McNutt et al[46] reported an acute MI in a 22-year-old bodybuilder who admitted

to AAS abuse but lacked cardiac risk factors. The patient presented with

markedly elevated LDL (596 mg/dl) and depressed HDL (14 mg/dl) yet had no family

history of premature atherosclerosis or cardiac events. Within a month of

discontinuing AAS, his LDL decreased to 220 mg/dl and his HDL increased to 35

mg/dl.

46 McNutt R.A., Ferenchick G.S., Kirlin P.C., Hamlin N.J.: Acute myocardial

infarction in a 22-year-old world class weight lifter using anabolic steroids.

Am J Cardiol62.164.1988; Citation

49 Bowman S.: Anabolic steroids and infarction. BMJ 300. 750.1990; Citation

Figure 1 shows the presenting electrocardiogram of a 25-year-old male athlete

who abused nandrolone and presented with an acute MI without traditional cardiac

risk factors. Acute angiography revealed extensive left anterior descending

coronary artery thrombosis, which was managed by thrombolysis. Angiography in

the subacute phase confirmed very mild luminal irregularity at the site of

previous thrombosis.

69 Kennedy C.: Myocardial infarction in association with misuse of anabolic

steroids. Ulster Med J 62. 174-176.1993; Citation

The most commonly observed arrhythmias, typically occurring during physical

exertion, include atrial fibrillation, ventricular fibrillation, ventricular

tachycardia, and supraventricular and ventricular ectopic beats. [95]

95 Furlanello F., Serdoz L.V., Cappato R., De Ambroggi L.: Illicit drugs and

cardiac arrhythmias in athletes. Eur J Cardiovasc Prev Rehabil 14. 487-494.2007;

Abstract

Dickerman et al [96] reported a 20-year-old male bodybuilder who

self-administered AAS 700 mg/week and had sudden cardiac arrest. Autopsy

indicated LVH with a cardiac mass >2 times the upper limit of normal.

96 Dickerman R.D., Schaller F., Prather I., McConathy W.J.: Sudden cardiac death

in a 20-year-old bodybuilder using anabolic steroids. Cardiology 86.

172-173.1995; Abstract

******************

Ralph Giarnella MD

Southington Ct. USA

Posted

The article only looked at cardiac effects of AAS. There is an alarming number

of suicides, amongst AAS users. The bodies are there if you just look for

them.

Ralph Giarnella MD

Southington Ct. USA

________________________________

From: " efreem3407@... " <efreem3407@...>

Supertraining

Sent: Wed, December 22, 2010 12:43:37 AM

Subject: Re: Anabolic steroids- where are the bodies.

You forgot about cancer. I know athletes that used AAS and ended up getting

cancer.

Edwin Freeman, Jr.

San Francisco, CA

Re: Anabolic steroids- where are the bodies.

A common refrain amongst apologists for anabolic steroids is : Where are the

bodies? The bodies are in the cemetary ony the death certificated does not

state they died from steroids. The most likely cause of death heart disease.

It might be cardiac arrhythmia or acute MI.

There is an excellent article in the American Journal of Cardiology which

reviews A total of 49 studies describing 1,467 athletes were reviewed to

investigate the cardiovascular effects of the abuse of AAS.

It cites 99 articles covering this topic. If you are interested in this topic

go to your local hospital Library and check out :

Cardiac and Metabolic Effects of Anabolic-Androgenic Steroid Abuse on Lipids,

Blood Pressure, Left Ventricular Dimensions, and

Rhythm

The American Journal of Cardiology - Volume 106, Issue 6 (September 2010) -

Copyright © 2010 The American College of Cardiology -

Because of copyright and space I cannot put the article here but I have taken

the time to excerpt some of the information I thought might be pertinent along

with the articles or journals cited.

You are not likely to find these studies in your typical muscle magazine or

website. Some of these studies date back to the mid 80s and 90s. The

information is not new just conveniently ignored.

***********************

Cardiac and Metabolic Effects of Anabolic-Androgenic Steroid Abuse on Lipids,

Blood Pressure, Left Ventricular Dimensions, and Rhythm

The American Journal of Cardiology - Volume 106, Issue 6 (September 2010) -

Copyright © 2010 The American College of Cardiology -

AAS and abnormal plasma lipoproteins

AAS abuse has been linked with abnormal plasma lipoproteins (Table 1). Several

studies suggest that AAS abuse in athletes increase low-density lipoprotein

(LDL)

levels by >20% [14] , [36] , [37] , [38] and decrease high-density lipoprotein

(HDL) levels by 20% to 70%. [13] , [14] , [37] , [39] , [40] , [41] , [42] ,

[43] , [44]

By some estimates, these lipoprotein abnormalities increase

the risk for coronary artery disease by three- to sixfold. [14] , [45]

13 Sader M.A., Griffiths K.A., McCredie R.J., Handelsman D.J., Celermajer

D.S.: Androgenic anabolic steroids and arterial structure and function in male

bodybuilders. J Am Coll Cardiol 37. 224-230.2001; Abstract

14 Lenders J.W., Demacker P.N., Vos J.A., Jansen P.L., Hoitsma A.J., Van't Laar

A., Thien T.: Deleterious effects of anabolic steroids on serum lipoproteins,

blood

pressure, and liver function in amateur bodybuilders. Int J Sports Med 9.

19-23.1988; Abstrac

36 Lajarin F., Zaragoza R., r I., ez- P.: Evolution of

serum lipids in two male bodybuilders using anabolic steroids. Clin Chem 42.

970-

972.1996; Abstract

37 McKillop G., Ballantyne D.: Lipoprotein analysis in bodybuilders. Int J

Cardiol 17. 281-288.1987; Abstract

38 Palatini P., Giada F., Garavelli G., Sinisi F., L., Michieletto M.,

Baldo-Enzi G.: Cardiovascular effects of anabolic steroids in weight-trained

subjects. J Clin

Pharmacol 36. 1132-1140.1996; Abstract

39 Baldo-Enzi G., Giada F., Zuliani G., Baroni L., Vitale E., Enzi G.,

Magnanini P., Fellin R.: Lipid and apoprotein modifications in body builders

during and after self-

administration of anabolic steroids. Metabolism 39. 203-208.1990; Abstract

40 Fröhlich J., Kullmer T., Urhausen A., Bergmann R., Kindermann W.: Lipid

profile of body builders with and without self-administration of anabolic

steroids. Eur J

Appl Physiol 59. 98-103.1989; 41 Hartgens F., Rietjens G., K

41 Hartgens F., Rietjens G., Keizer H.A., Kuipers H., Wolffenbuttel B.:

Effects of androgenic-anabolic steroids on apolipoproteins and lipoprotein (a).

Br J Sport

Med 38. 253-259.2004;

42 Lane H., Grace F., J.C., K., Cockcroft J., Scanlon M.F., Davies

J.S.: Impaired vasoreactivity in bodybuilders using androgenic anabolic

steroids. Eur J

Clin Invest 36. 483-488.2006; Abstract

43 Urhausen A., Albers T., Kindermann W.: Are the cardiac effects of anabolic

steroid abuse in strength athletes reversible?. Heart 90. 496-501.2004;

Abstract

44 Zuliani U., Bernardini B., Catapano A., Campana M., Cerioli G., Spattini

M.: Effects of anabolic steroids, testosterone, and HGH on blood lipids and

echocardiographic parameteres in body builders. Int J Sports Med 10.

62-66.1989; Abstract

45 Glazer G.: Atherogenic effects of anabolic steroids on serum lipid levels.

A literature reviewArch Intern Med 151. 1925-1933.1991; Abstract

AAS, acute MI, and sudden death

Alarming data have linked AAS with fatal events, although these are mostly

case-control studies and case reports of acute coronary syndromes, MIs, and

ventricular

arrhythmias. [24] , [46] , [83] , [84] , [85] , [86] , [87] , [88]

88 Fineschi V., Riezzo I., Centini F., Silingardi E., Licata M., Beduschi G.,

Karch S.B.: Sudden cardiac death during anabolic steroid abuse: morphologic and

toxicologic findings in two fatal cases of bodybuilders. Int J Legal Med 121.

48-53.2007; Abstract

89 Sullivan M.L., ez C.M., Gennis P., Gallagher E.J.: The cardiac

toxicity of anabolic steroids. Prog Cardiovasc Dis 41. 1-15.1998; Abstract

90 Ferenchick G.: Anabolic/androgenic steroid abuse and thrombosis: is there a

connection?. Med Hypotheses 35. 27-31.1991; Abstract

91 Roeggia M., Heinz G., Werba E., Roeggla G.: Cardiac tamponade in a

21-year-old body builder with anabolica abuse. Br J Clin Pract 50.

411-412.1996; Citation

92 Ferenchick G., Adelman S.: Myocardial infarction associated with anabolic

steroid use in a previously healthy 37-year-old weight lifter. Am Heart J 124.

507-

508.1992; Citation

93 Huie M.: An acute myocardial infarction occurring in an anabolic steroid

user. Med Sci Sport Exer 26. 408-413.1994;

94 Fisher M., Appleby M., Rittoo D., Cotter L.: Myocardial infarction with

extensive intracoronary thrombus induced by anabolic steroids. Br J Clin Pract

50. 222-

223.1996; Abstract

a postmortem study of male Caucasian AAS abusers (aged 20 to 45 years) suggested

primary cardiac pathology in 1/3, [23]

23 Thiblin I., Lindquist O., Rajs J.: Cause and manner of death among users of

anabolic androgenic steroids. J Forensic Sci 45. 16-23.2000; Abstract

recent case-control study [24] , [25] suggested cardiac causes in 2/3 of deaths,

with others being attributed to suicide, hepatic coma, and malignancy.

24 Parssinen M., Kujala U., Vartiainen E., Sarna S., Seppala T.: Increased

premature mortality of competitive powerlifters suspected to have used anabolic

agents. Int J Sports Med 21. 225-227.2000; Abstrac

25 Parssinen M., Seppala T.: Steroid use and long-term health risks in former

athletes. Sports Med 2002. 83-84.2002; 2

Hausmann et al [84] describe a 23-year-old male bodybuilder who abused AAS and

experienced sudden cardiac arrest. Postmortem examination revealed ventricular

hypertrophy, myocardial fibrosis, and acute MI, and the cause of death was

attributed to arrhythmic sudden death secondary to AAS abuse.

84 Hausmann R., Hammer S., Betz P.: Performance enhancing drugs (doping agents)

and sudden death—a case report and review of the literature. Int J Legal Med

111. 261-264.1998; Abstrac

McNutt et al[46] reported an acute MI in a 22-year-old bodybuilder who admitted

to AAS abuse but lacked cardiac risk factors. The patient presented with

markedly elevated LDL (596 mg/dl) and depressed HDL (14 mg/dl) yet had no family

history of premature atherosclerosis or cardiac events. Within a month of

discontinuing AAS, his LDL decreased to 220 mg/dl and his HDL increased to 35

mg/dl.

46 McNutt R.A., Ferenchick G.S., Kirlin P.C., Hamlin N.J.: Acute myocardial

infarction in a 22-year-old world class weight lifter using anabolic steroids.

Am J Cardiol62.164.1988; Citation

49 Bowman S.: Anabolic steroids and infarction. BMJ 300. 750.1990; Citation

Figure 1 shows the presenting electrocardiogram of a 25-year-old male athlete

who abused nandrolone and presented with an acute MI without traditional cardiac

risk factors. Acute angiography revealed extensive left anterior descending

coronary artery thrombosis, which was managed by thrombolysis. Angiography in

the subacute phase confirmed very mild luminal irregularity at the site of

previous thrombosis.

69 Kennedy C.: Myocardial infarction in association with misuse of anabolic

steroids. Ulster Med J 62. 174-176.1993; Citation

The most commonly observed arrhythmias, typically occurring during physical

exertion, include atrial fibrillation, ventricular fibrillation, ventricular

tachycardia, and supraventricular and ventricular ectopic beats. [95]

95 Furlanello F., Serdoz L.V., Cappato R., De Ambroggi L.: Illicit drugs and

cardiac arrhythmias in athletes. Eur J Cardiovasc Prev Rehabil 14. 487-494.2007;

Abstract

Dickerman et al [96] reported a 20-year-old male bodybuilder who

self-administered AAS 700 mg/week and had sudden cardiac arrest. Autopsy

indicated LVH with a cardiac mass >2 times the upper limit of normal.

96 Dickerman R.D., Schaller F., Prather I., McConathy W.J.: Sudden cardiac death

in a 20-year-old bodybuilder using anabolic steroids. Cardiology 86.

172-173.1995; Abstract

******************

Ralph Giarnella MD

Southington Ct. USA

Posted

A common refrain amongst apologists against anabolic steroids is: The bodies are

in the cemetary only the death certificate does not state they died from

steriods.

Kenny Croxdale

Rio Rancho, NM

Re: Anabolic steroids- where are the bodies.

A common refrain amongst apologists for anabolic steroids is : Where are the

bodies? The bodies are in the cemetary ony the death certificated does not

state they died from steroids. The most likely cause of death heart disease.

It might be cardiac arrhythmia or acute MI.

There is an excellent article in the American Journal of Cardiology which

reviews A total of 49 studies describing 1,467 athletes were reviewed to

investigate the cardiovascular effects of the abuse of AAS.

It cites 99 articles covering this topic. If you are interested in this topic

go to your local hospital Library and check out :

Cardiac and Metabolic Effects of Anabolic-Androgenic Steroid Abuse on Lipids,

Blood Pressure, Left Ventricular Dimensions, and

Rhythm

The American Journal of Cardiology - Volume 106, Issue 6 (September 2010) -

Copyright © 2010 The American College of Cardiology -

Because of copyright and space I cannot put the article here but I have taken

the time to excerpt some of the information I thought might be pertinent along

with the articles or journals cited.

You are not likely to find these studies in your typical muscle magazine or

website. Some of these studies date back to the mid 80s and 90s. The

information is not new just conveniently ignored.

***********************

Cardiac and Metabolic Effects of Anabolic-Androgenic Steroid Abuse on Lipids,

Blood Pressure, Left Ventricular Dimensions, and Rhythm

The American Journal of Cardiology - Volume 106, Issue 6 (September 2010) -

Copyright © 2010 The American College of Cardiology -

AAS and abnormal plasma lipoproteins

AAS abuse has been linked with abnormal plasma lipoproteins (Table 1). Several

studies suggest that AAS abuse in athletes increase low-density lipoprotein

(LDL)

levels by >20% [14] , [36] , [37] , [38] and decrease high-density lipoprotein

(HDL) levels by 20% to 70%. [13] , [14] , [37] , [39] , [40] , [41] , [42] ,

[43] , [44]

By some estimates, these lipoprotein abnormalities increase

the risk for coronary artery disease by three- to sixfold. [14] , [45]

13 Sader M.A., Griffiths K.A., McCredie R.J., Handelsman D.J., Celermajer

D.S.: Androgenic anabolic steroids and arterial structure and function in male

bodybuilders. J Am Coll Cardiol 37. 224-230.2001; Abstract

14 Lenders J.W., Demacker P.N., Vos J.A., Jansen P.L., Hoitsma A.J., Van't Laar

A., Thien T.: Deleterious effects of anabolic steroids on serum lipoproteins,

blood

pressure, and liver function in amateur bodybuilders. Int J Sports Med 9.

19-23.1988; Abstrac

36 Lajarin F., Zaragoza R., r I., ez- P.: Evolution of

serum lipids in two male bodybuilders using anabolic steroids. Clin Chem 42.

970-

972.1996; Abstract

37 McKillop G., Ballantyne D.: Lipoprotein analysis in bodybuilders. Int J

Cardiol 17. 281-288.1987; Abstract

38 Palatini P., Giada F., Garavelli G., Sinisi F., L., Michieletto M.,

Baldo-Enzi G.: Cardiovascular effects of anabolic steroids in weight-trained

subjects. J Clin

Pharmacol 36. 1132-1140.1996; Abstract

39 Baldo-Enzi G., Giada F., Zuliani G., Baroni L., Vitale E., Enzi G.,

Magnanini P., Fellin R.: Lipid and apoprotein modifications in body builders

during and after self-

administration of anabolic steroids. Metabolism 39. 203-208.1990; Abstract

40 Fröhlich J., Kullmer T., Urhausen A., Bergmann R., Kindermann W.: Lipid

profile of body builders with and without self-administration of anabolic

steroids. Eur J

Appl Physiol 59. 98-103.1989; 41 Hartgens F., Rietjens G., K

41 Hartgens F., Rietjens G., Keizer H.A., Kuipers H., Wolffenbuttel B.:

Effects of androgenic-anabolic steroids on apolipoproteins and lipoprotein (a).

Br J Sport

Med 38. 253-259.2004;

42 Lane H., Grace F., J.C., K., Cockcroft J., Scanlon M.F., Davies

J.S.: Impaired vasoreactivity in bodybuilders using androgenic anabolic

steroids. Eur J

Clin Invest 36. 483-488.2006; Abstract

43 Urhausen A., Albers T., Kindermann W.: Are the cardiac effects of anabolic

steroid abuse in strength athletes reversible?. Heart 90. 496-501.2004;

Abstract

44 Zuliani U., Bernardini B., Catapano A., Campana M., Cerioli G., Spattini

M.: Effects of anabolic steroids, testosterone, and HGH on blood lipids and

echocardiographic parameteres in body builders. Int J Sports Med 10.

62-66.1989; Abstract

45 Glazer G.: Atherogenic effects of anabolic steroids on serum lipid levels.

A literature reviewArch Intern Med 151. 1925-1933.1991; Abstract

AAS, acute MI, and sudden death

Alarming data have linked AAS with fatal events, although these are mostly

case-control studies and case reports of acute coronary syndromes, MIs, and

ventricular

arrhythmias. [24] , [46] , [83] , [84] , [85] , [86] , [87] , [88]

88 Fineschi V., Riezzo I., Centini F., Silingardi E., Licata M., Beduschi G.,

Karch S.B.: Sudden cardiac death during anabolic steroid abuse: morphologic and

toxicologic findings in two fatal cases of bodybuilders. Int J Legal Med 121.

48-53.2007; Abstract

89 Sullivan M.L., ez C.M., Gennis P., Gallagher E.J.: The cardiac

toxicity of anabolic steroids. Prog Cardiovasc Dis 41. 1-15.1998; Abstract

90 Ferenchick G.: Anabolic/androgenic steroid abuse and thrombosis: is there a

connection?. Med Hypotheses 35. 27-31.1991; Abstract

91 Roeggia M., Heinz G., Werba E., Roeggla G.: Cardiac tamponade in a

21-year-old body builder with anabolica abuse. Br J Clin Pract 50.

411-412.1996; Citation

92 Ferenchick G., Adelman S.: Myocardial infarction associated with anabolic

steroid use in a previously healthy 37-year-old weight lifter. Am Heart J 124.

507-

508.1992; Citation

93 Huie M.: An acute myocardial infarction occurring in an anabolic steroid

user. Med Sci Sport Exer 26. 408-413.1994;

94 Fisher M., Appleby M., Rittoo D., Cotter L.: Myocardial infarction with

extensive intracoronary thrombus induced by anabolic steroids. Br J Clin Pract

50. 222-

223.1996; Abstract

a postmortem study of male Caucasian AAS abusers (aged 20 to 45 years) suggested

primary cardiac pathology in 1/3, [23]

23 Thiblin I., Lindquist O., Rajs J.: Cause and manner of death among users of

anabolic androgenic steroids. J Forensic Sci 45. 16-23.2000; Abstract

recent case-control study [24] , [25] suggested cardiac causes in 2/3 of deaths,

with others being attributed to suicide, hepatic coma, and malignancy.

24 Parssinen M., Kujala U., Vartiainen E., Sarna S., Seppala T.: Increased

premature mortality of competitive powerlifters suspected to have used anabolic

agents. Int J Sports Med 21. 225-227.2000; Abstrac

25 Parssinen M., Seppala T.: Steroid use and long-term health risks in former

athletes. Sports Med 2002. 83-84.2002; 2

Hausmann et al [84] describe a 23-year-old male bodybuilder who abused AAS and

experienced sudden cardiac arrest. Postmortem examination revealed ventricular

hypertrophy, myocardial fibrosis, and acute MI, and the cause of death was

attributed to arrhythmic sudden death secondary to AAS abuse.

84 Hausmann R., Hammer S., Betz P.: Performance enhancing drugs (doping agents)

and sudden death—a case report and review of the literature. Int J Legal Med

111. 261-264.1998; Abstrac

McNutt et al[46] reported an acute MI in a 22-year-old bodybuilder who admitted

to AAS abuse but lacked cardiac risk factors. The patient presented with

markedly elevated LDL (596 mg/dl) and depressed HDL (14 mg/dl) yet had no family

history of premature atherosclerosis or cardiac events. Within a month of

discontinuing AAS, his LDL decreased to 220 mg/dl and his HDL increased to 35

mg/dl.

46 McNutt R.A., Ferenchick G.S., Kirlin P.C., Hamlin N.J.: Acute myocardial

infarction in a 22-year-old world class weight lifter using anabolic steroids.

Am J Cardiol62.164.1988; Citation

49 Bowman S.: Anabolic steroids and infarction. BMJ 300. 750.1990; Citation

Figure 1 shows the presenting electrocardiogram of a 25-year-old male athlete

who abused nandrolone and presented with an acute MI without traditional cardiac

risk factors. Acute angiography revealed extensive left anterior descending

coronary artery thrombosis, which was managed by thrombolysis. Angiography in

the subacute phase confirmed very mild luminal irregularity at the site of

previous thrombosis.

69 Kennedy C.: Myocardial infarction in association with misuse of anabolic

steroids. Ulster Med J 62. 174-176.1993; Citation

The most commonly observed arrhythmias, typically occurring during physical

exertion, include atrial fibrillation, ventricular fibrillation, ventricular

tachycardia, and supraventricular and ventricular ectopic beats. [95]

95 Furlanello F., Serdoz L.V., Cappato R., De Ambroggi L.: Illicit drugs and

cardiac arrhythmias in athletes. Eur J Cardiovasc Prev Rehabil 14. 487-494.2007;

Abstract

Dickerman et al [96] reported a 20-year-old male bodybuilder who

self-administered AAS 700 mg/week and had sudden cardiac arrest. Autopsy

indicated LVH with a cardiac mass >2 times the upper limit of normal.

96 Dickerman R.D., Schaller F., Prather I., McConathy W.J.: Sudden cardiac death

in a 20-year-old bodybuilder using anabolic steroids. Cardiology 86.

172-173.1995; Abstract

******************

Ralph Giarnella MD

Southington Ct. USA

Posted

Ralph,

What data do you have to back that statement up on suicides?

Evidently, you have yet to find the bodies. So, either they aren't there or you

don't know where to look. Which is it?

Kenny Croxdale

Rio Rancho, NM

Re: Anabolic steroids- where are the bodies.

A common refrain amongst apologists for anabolic steroids is : Where are the

bodies? The bodies are in the cemetary ony the death certificated does not

state they died from steroids. The most likely cause of death heart disease.

It might be cardiac arrhythmia or acute MI.

There is an excellent article in the American Journal of Cardiology which

reviews A total of 49 studies describing 1,467 athletes were reviewed to

investigate the cardiovascular effects of the abuse of AAS.

It cites 99 articles covering this topic. If you are interested in this topic

go to your local hospital Library and check out :

Cardiac and Metabolic Effects of Anabolic-Androgenic Steroid Abuse on Lipids,

Blood Pressure, Left Ventricular Dimensions, and

Rhythm

The American Journal of Cardiology - Volume 106, Issue 6 (September 2010) -

Copyright © 2010 The American College of Cardiology -

Because of copyright and space I cannot put the article here but I have taken

the time to excerpt some of the information I thought might be pertinent along

with the articles or journals cited.

You are not likely to find these studies in your typical muscle magazine or

website. Some of these studies date back to the mid 80s and 90s. The

information is not new just conveniently ignored.

***********************

Cardiac and Metabolic Effects of Anabolic-Androgenic Steroid Abuse on Lipids,

Blood Pressure, Left Ventricular Dimensions, and Rhythm

The American Journal of Cardiology - Volume 106, Issue 6 (September 2010) -

Copyright © 2010 The American College of Cardiology -

AAS and abnormal plasma lipoproteins

AAS abuse has been linked with abnormal plasma lipoproteins (Table 1). Several

studies suggest that AAS abuse in athletes increase low-density lipoprotein

(LDL)

levels by >20% [14] , [36] , [37] , [38] and decrease high-density lipoprotein

(HDL) levels by 20% to 70%. [13] , [14] , [37] , [39] , [40] , [41] , [42] ,

[43] , [44]

By some estimates, these lipoprotein abnormalities increase

the risk for coronary artery disease by three- to sixfold. [14] , [45]

13 Sader M.A., Griffiths K.A., McCredie R.J., Handelsman D.J., Celermajer

D.S.: Androgenic anabolic steroids and arterial structure and function in male

bodybuilders. J Am Coll Cardiol 37. 224-230.2001; Abstract

14 Lenders J.W., Demacker P.N., Vos J.A., Jansen P.L., Hoitsma A.J., Van't Laar

A., Thien T.: Deleterious effects of anabolic steroids on serum lipoproteins,

blood

pressure, and liver function in amateur bodybuilders. Int J Sports Med 9.

19-23.1988; Abstrac

36 Lajarin F., Zaragoza R., r I., ez- P.: Evolution of

serum lipids in two male bodybuilders using anabolic steroids. Clin Chem 42.

970-

972.1996; Abstract

37 McKillop G., Ballantyne D.: Lipoprotein analysis in bodybuilders. Int J

Cardiol 17. 281-288.1987; Abstract

38 Palatini P., Giada F., Garavelli G., Sinisi F., L., Michieletto M.,

Baldo-Enzi G.: Cardiovascular effects of anabolic steroids in weight-trained

subjects. J Clin

Pharmacol 36. 1132-1140.1996; Abstract

39 Baldo-Enzi G., Giada F., Zuliani G., Baroni L., Vitale E., Enzi G.,

Magnanini P., Fellin R.: Lipid and apoprotein modifications in body builders

during and after self-

administration of anabolic steroids. Metabolism 39. 203-208.1990; Abstract

40 Fröhlich J., Kullmer T., Urhausen A., Bergmann R., Kindermann W.: Lipid

profile of body builders with and without self-administration of anabolic

steroids. Eur J

Appl Physiol 59. 98-103.1989; 41 Hartgens F., Rietjens G., K

41 Hartgens F., Rietjens G., Keizer H.A., Kuipers H., Wolffenbuttel B.:

Effects of androgenic-anabolic steroids on apolipoproteins and lipoprotein (a).

Br J Sport

Med 38. 253-259.2004;

42 Lane H., Grace F., J.C., K., Cockcroft J., Scanlon M.F., Davies

J.S.: Impaired vasoreactivity in bodybuilders using androgenic anabolic

steroids. Eur J

Clin Invest 36. 483-488.2006; Abstract

43 Urhausen A., Albers T., Kindermann W.: Are the cardiac effects of anabolic

steroid abuse in strength athletes reversible?. Heart 90. 496-501.2004;

Abstract

44 Zuliani U., Bernardini B., Catapano A., Campana M., Cerioli G., Spattini

M.: Effects of anabolic steroids, testosterone, and HGH on blood lipids and

echocardiographic parameteres in body builders. Int J Sports Med 10.

62-66.1989; Abstract

45 Glazer G.: Atherogenic effects of anabolic steroids on serum lipid levels.

A literature reviewArch Intern Med 151. 1925-1933.1991; Abstract

AAS, acute MI, and sudden death

Alarming data have linked AAS with fatal events, although these are mostly

case-control studies and case reports of acute coronary syndromes, MIs, and

ventricular

arrhythmias. [24] , [46] , [83] , [84] , [85] , [86] , [87] , [88]

88 Fineschi V., Riezzo I., Centini F., Silingardi E., Licata M., Beduschi G.,

Karch S.B.: Sudden cardiac death during anabolic steroid abuse: morphologic and

toxicologic findings in two fatal cases of bodybuilders. Int J Legal Med 121.

48-53.2007; Abstract

89 Sullivan M.L., ez C.M., Gennis P., Gallagher E.J.: The cardiac

toxicity of anabolic steroids. Prog Cardiovasc Dis 41. 1-15.1998; Abstract

90 Ferenchick G.: Anabolic/androgenic steroid abuse and thrombosis: is there a

connection?. Med Hypotheses 35. 27-31.1991; Abstract

91 Roeggia M., Heinz G., Werba E., Roeggla G.: Cardiac tamponade in a

21-year-old body builder with anabolica abuse. Br J Clin Pract 50.

411-412.1996; Citation

92 Ferenchick G., Adelman S.: Myocardial infarction associated with anabolic

steroid use in a previously healthy 37-year-old weight lifter. Am Heart J 124.

507-

508.1992; Citation

93 Huie M.: An acute myocardial infarction occurring in an anabolic steroid

user. Med Sci Sport Exer 26. 408-413.1994;

94 Fisher M., Appleby M., Rittoo D., Cotter L.: Myocardial infarction with

extensive intracoronary thrombus induced by anabolic steroids. Br J Clin Pract

50. 222-

223.1996; Abstract

a postmortem study of male Caucasian AAS abusers (aged 20 to 45 years) suggested

primary cardiac pathology in 1/3, [23]

23 Thiblin I., Lindquist O., Rajs J.: Cause and manner of death among users of

anabolic androgenic steroids. J Forensic Sci 45. 16-23.2000; Abstract

recent case-control study [24] , [25] suggested cardiac causes in 2/3 of deaths,

with others being attributed to suicide, hepatic coma, and malignancy.

24 Parssinen M., Kujala U., Vartiainen E., Sarna S., Seppala T.: Increased

premature mortality of competitive powerlifters suspected to have used anabolic

agents. Int J Sports Med 21. 225-227.2000; Abstrac

25 Parssinen M., Seppala T.: Steroid use and long-term health risks in former

athletes. Sports Med 2002. 83-84.2002; 2

Hausmann et al [84] describe a 23-year-old male bodybuilder who abused AAS and

experienced sudden cardiac arrest. Postmortem examination revealed ventricular

hypertrophy, myocardial fibrosis, and acute MI, and the cause of death was

attributed to arrhythmic sudden death secondary to AAS abuse.

84 Hausmann R., Hammer S., Betz P.: Performance enhancing drugs (doping agents)

and sudden death—a case report and review of the literature. Int J Legal Med

111. 261-264.1998; Abstrac

McNutt et al[46] reported an acute MI in a 22-year-old bodybuilder who admitted

to AAS abuse but lacked cardiac risk factors. The patient presented with

markedly elevated LDL (596 mg/dl) and depressed HDL (14 mg/dl) yet had no family

history of premature atherosclerosis or cardiac events. Within a month of

discontinuing AAS, his LDL decreased to 220 mg/dl and his HDL increased to 35

mg/dl.

46 McNutt R.A., Ferenchick G.S., Kirlin P.C., Hamlin N.J.: Acute myocardial

infarction in a 22-year-old world class weight lifter using anabolic steroids.

Am J Cardiol62.164.1988; Citation

49 Bowman S.: Anabolic steroids and infarction. BMJ 300. 750.1990; Citation

Figure 1 shows the presenting electrocardiogram of a 25-year-old male athlete

who abused nandrolone and presented with an acute MI without traditional cardiac

risk factors. Acute angiography revealed extensive left anterior descending

coronary artery thrombosis, which was managed by thrombolysis. Angiography in

the subacute phase confirmed very mild luminal irregularity at the site of

previous thrombosis.

69 Kennedy C.: Myocardial infarction in association with misuse of anabolic

steroids. Ulster Med J 62. 174-176.1993; Citation

The most commonly observed arrhythmias, typically occurring during physical

exertion, include atrial fibrillation, ventricular fibrillation, ventricular

tachycardia, and supraventricular and ventricular ectopic beats. [95]

95 Furlanello F., Serdoz L.V., Cappato R., De Ambroggi L.: Illicit drugs and

cardiac arrhythmias in athletes. Eur J Cardiovasc Prev Rehabil 14. 487-494.2007;

Abstract

Dickerman et al [96] reported a 20-year-old male bodybuilder who

self-administered AAS 700 mg/week and had sudden cardiac arrest. Autopsy

indicated LVH with a cardiac mass >2 times the upper limit of normal.

96 Dickerman R.D., Schaller F., Prather I., McConathy W.J.: Sudden cardiac death

in a 20-year-old bodybuilder using anabolic steroids. Cardiology 86.

172-173.1995; Abstract

******************

Ralph Giarnella MD

Southington Ct. USA

Posted

You apparently missed the point of the article. There are numerous case studies

of young weight lifters and body builders who abused AAS and died and

subsequently underwent autopsy. These are individuals who had no other risk

factors for heart disease. When a person dies of heart disease because of a bad

diet the death certificate does not state that they died because they had a poor

diet. It just states they died of a heart attack. Death certificates do not

state that an individual died because of obesity nor does it state that they

died as the result of smoking. Death certificates list the conditions caused by

these conditions such as heart diseasea, diabetes, emphysema or copd. As a

matter of fact in my state (Connecticut) only recently has there been a box to

check off is smoking might have been a contributing cause of this persons

death. There is no box to check for alcohol abuse, obesity or eating at

Mcs. a

There is plenty of science available in the literature concerning the dangers of

AAS, however the AAS apologists conveninetly ignore the science.

Ralph Giarnella MD

Southington Ct. USA

________________________________

From: " KennyCrox@... " <KennyCrox@...>

Supertraining

Sent: Wed, December 22, 2010 7:00:59 AM

Subject: Re: Anabolic steroids- where are the bodies.

A common refrain amongst apologists against anabolic steroids is: The bodies are

in the cemetary only the death certificate does not state they died from

steriods.

Kenny Croxdale

Rio Rancho, NM

Re: Anabolic steroids- where are the bodies.

A common refrain amongst apologists for anabolic steroids is : Where are the

bodies? The bodies are in the cemetary ony the death certificated does not

state they died from steroids. The most likely cause of death heart disease.

It might be cardiac arrhythmia or acute MI.

There is an excellent article in the American Journal of Cardiology which

reviews A total of 49 studies describing 1,467 athletes were reviewed to

investigate the cardiovascular effects of the abuse of AAS.

It cites 99 articles covering this topic. If you are interested in this topic

go to your local hospital Library and check out :

Cardiac and Metabolic Effects of Anabolic-Androgenic Steroid Abuse on Lipids,

Blood Pressure, Left Ventricular Dimensions, and

Rhythm

The American Journal of Cardiology - Volume 106, Issue 6 (September 2010) -

Copyright © 2010 The American College of Cardiology -

Because of copyright and space I cannot put the article here but I have taken

the time to excerpt some of the information I thought might be pertinent along

with the articles or journals cited.

You are not likely to find these studies in your typical muscle magazine or

website. Some of these studies date back to the mid 80s and 90s. The

information is not new just conveniently ignored.

***********************

Cardiac and Metabolic Effects of Anabolic-Androgenic Steroid Abuse on Lipids,

Blood Pressure, Left Ventricular Dimensions, and Rhythm

The American Journal of Cardiology - Volume 106, Issue 6 (September 2010) -

Copyright © 2010 The American College of Cardiology -

AAS and abnormal plasma lipoproteins

AAS abuse has been linked with abnormal plasma lipoproteins (Table 1). Several

studies suggest that AAS abuse in athletes increase low-density lipoprotein

(LDL)

levels by >20% [14] , [36] , [37] , [38] and decrease high-density lipoprotein

(HDL) levels by 20% to 70%. [13] , [14] , [37] , [39] , [40] , [41] , [42] ,

[43] , [44]

By some estimates, these lipoprotein abnormalities increase

the risk for coronary artery disease by three- to sixfold. [14] , [45]

13 Sader M.A., Griffiths K.A., McCredie R.J., Handelsman D.J., Celermajer

D.S.: Androgenic anabolic steroids and arterial structure and function in male

bodybuilders. J Am Coll Cardiol 37. 224-230.2001; Abstract

14 Lenders J.W., Demacker P.N., Vos J.A., Jansen P.L., Hoitsma A.J., Van't Laar

A., Thien T.: Deleterious effects of anabolic steroids on serum lipoproteins,

blood

pressure, and liver function in amateur bodybuilders. Int J Sports Med 9.

19-23.1988; Abstrac

36 Lajarin F., Zaragoza R., r I., ez- P.: Evolution of

serum lipids in two male bodybuilders using anabolic steroids. Clin Chem 42.

970-

972.1996; Abstract

37 McKillop G., Ballantyne D.: Lipoprotein analysis in bodybuilders. Int J

Cardiol 17. 281-288.1987; Abstract

38 Palatini P., Giada F., Garavelli G., Sinisi F., L., Michieletto M.,

Baldo-Enzi G.: Cardiovascular effects of anabolic steroids in weight-trained

subjects. J Clin

Pharmacol 36. 1132-1140.1996; Abstract

39 Baldo-Enzi G., Giada F., Zuliani G., Baroni L., Vitale E., Enzi G.,

Magnanini P., Fellin R.: Lipid and apoprotein modifications in body builders

during and after self-

administration of anabolic steroids. Metabolism 39. 203-208.1990; Abstract

40 Fröhlich J., Kullmer T., Urhausen A., Bergmann R., Kindermann W.: Lipid

profile of body builders with and without self-administration of anabolic

steroids. Eur J

Appl Physiol 59. 98-103.1989; 41 Hartgens F., Rietjens G., K

41 Hartgens F., Rietjens G., Keizer H.A., Kuipers H., Wolffenbuttel B.:

Effects of androgenic-anabolic steroids on apolipoproteins and lipoprotein (a).

Br J Sport

Med 38. 253-259.2004;

42 Lane H., Grace F., J.C., K., Cockcroft J., Scanlon M.F., Davies

J.S.: Impaired vasoreactivity in bodybuilders using androgenic anabolic

steroids. Eur J

Clin Invest 36. 483-488.2006; Abstract

43 Urhausen A., Albers T., Kindermann W.: Are the cardiac effects of anabolic

steroid abuse in strength athletes reversible?. Heart 90. 496-501.2004;

Abstract

44 Zuliani U., Bernardini B., Catapano A., Campana M., Cerioli G., Spattini

M.: Effects of anabolic steroids, testosterone, and HGH on blood lipids and

echocardiographic parameteres in body builders. Int J Sports Med 10.

62-66.1989; Abstract

45 Glazer G.: Atherogenic effects of anabolic steroids on serum lipid levels.

A literature reviewArch Intern Med 151. 1925-1933.1991; Abstract

AAS, acute MI, and sudden death

Alarming data have linked AAS with fatal events, although these are mostly

case-control studies and case reports of acute coronary syndromes, MIs, and

ventricular

arrhythmias. [24] , [46] , [83] , [84] , [85] , [86] , [87] , [88]

88 Fineschi V., Riezzo I., Centini F., Silingardi E., Licata M., Beduschi G.,

Karch S.B.: Sudden cardiac death during anabolic steroid abuse: morphologic and

toxicologic findings in two fatal cases of bodybuilders. Int J Legal Med 121.

48-53.2007; Abstract

89 Sullivan M.L., ez C.M., Gennis P., Gallagher E.J.: The cardiac

toxicity of anabolic steroids. Prog Cardiovasc Dis 41. 1-15.1998; Abstract

90 Ferenchick G.: Anabolic/androgenic steroid abuse and thrombosis: is there a

connection?. Med Hypotheses 35. 27-31.1991; Abstract

91 Roeggia M., Heinz G., Werba E., Roeggla G.: Cardiac tamponade in a

21-year-old body builder with anabolica abuse. Br J Clin Pract 50.

411-412.1996; Citation

92 Ferenchick G., Adelman S.: Myocardial infarction associated with anabolic

steroid use in a previously healthy 37-year-old weight lifter. Am Heart J 124.

507-

508.1992; Citation

93 Huie M.: An acute myocardial infarction occurring in an anabolic steroid

user. Med Sci Sport Exer 26. 408-413.1994;

94 Fisher M., Appleby M., Rittoo D., Cotter L.: Myocardial infarction with

extensive intracoronary thrombus induced by anabolic steroids. Br J Clin Pract

50. 222-

223.1996; Abstract

a postmortem study of male Caucasian AAS abusers (aged 20 to 45 years) suggested

primary cardiac pathology in 1/3, [23]

23 Thiblin I., Lindquist O., Rajs J.: Cause and manner of death among users of

anabolic androgenic steroids. J Forensic Sci 45. 16-23.2000; Abstract

recent case-control study [24] , [25] suggested cardiac causes in 2/3 of deaths,

with others being attributed to suicide, hepatic coma, and malignancy.

24 Parssinen M., Kujala U., Vartiainen E., Sarna S., Seppala T.: Increased

premature mortality of competitive powerlifters suspected to have used anabolic

agents. Int J Sports Med 21. 225-227.2000; Abstrac

25 Parssinen M., Seppala T.: Steroid use and long-term health risks in former

athletes. Sports Med 2002. 83-84.2002; 2

Hausmann et al [84] describe a 23-year-old male bodybuilder who abused AAS and

experienced sudden cardiac arrest. Postmortem examination revealed ventricular

hypertrophy, myocardial fibrosis, and acute MI, and the cause of death was

attributed to arrhythmic sudden death secondary to AAS abuse.

84 Hausmann R., Hammer S., Betz P.: Performance enhancing drugs (doping agents)

and sudden death—a case report and review of the literature. Int J Legal Med

111. 261-264.1998; Abstrac

McNutt et al[46] reported an acute MI in a 22-year-old bodybuilder who admitted

to AAS abuse but lacked cardiac risk factors. The patient presented with

markedly elevated LDL (596 mg/dl) and depressed HDL (14 mg/dl) yet had no family

history of premature atherosclerosis or cardiac events. Within a month of

discontinuing AAS, his LDL decreased to 220 mg/dl and his HDL increased to 35

mg/dl.

46 McNutt R.A., Ferenchick G.S., Kirlin P.C., Hamlin N.J.: Acute myocardial

infarction in a 22-year-old world class weight lifter using anabolic steroids.

Am J Cardiol62.164.1988; Citation

49 Bowman S.: Anabolic steroids and infarction. BMJ 300. 750.1990; Citation

Figure 1 shows the presenting electrocardiogram of a 25-year-old male athlete

who abused nandrolone and presented with an acute MI without traditional cardiac

risk factors. Acute angiography revealed extensive left anterior descending

coronary artery thrombosis, which was managed by thrombolysis. Angiography in

the subacute phase confirmed very mild luminal irregularity at the site of

previous thrombosis.

69 Kennedy C.: Myocardial infarction in association with misuse of anabolic

steroids. Ulster Med J 62. 174-176.1993; Citation

The most commonly observed arrhythmias, typically occurring during physical

exertion, include atrial fibrillation, ventricular fibrillation, ventricular

tachycardia, and supraventricular and ventricular ectopic beats. [95]

95 Furlanello F., Serdoz L.V., Cappato R., De Ambroggi L.: Illicit drugs and

cardiac arrhythmias in athletes. Eur J Cardiovasc Prev Rehabil 14. 487-494.2007;

Abstract

Dickerman et al [96] reported a 20-year-old male bodybuilder who

self-administered AAS 700 mg/week and had sudden cardiac arrest. Autopsy

indicated LVH with a cardiac mass >2 times the upper limit of normal.

96 Dickerman R.D., Schaller F., Prather I., McConathy W.J.: Sudden cardiac death

in a 20-year-old bodybuilder using anabolic steroids. Cardiology 86.

172-173.1995; Abstract

******************

Ralph Giarnella MD

Southington Ct. USA

Posted

The same article cited several studies with the data concerning suicides. Take

the time and go to your local hospital library and you will find the original

article. You can read it for yourself. As I stated in my original post the

article lists 99 published studies on the subject of cardiac effects of AAS.

*********************

a recent case-control study [24] , [25] suggested cardiac causes in 2/3 of

deaths, with others being attributed to suicide, hepatic coma, and malignancy.

24 Parssinen M., Kujala U., Vartiainen E., Sarna S., Seppala T.: Increased

premature mortality of competitive powerlifters suspected to have used anabolic

agents. Int J Sports Med 21. 225-227.2000; Abstract

25 Parssinen M., Seppala T.: Steroid use and long-term health risks in former

athletes. Sports Med 2002. 83-84.2002;

******************

Ralph Giarnella MD

Southington Ct. USA

________________________________

From: " KennyCrox@... " <KennyCrox@...>

Supertraining ; ragiarn@...

Sent: Wed, December 22, 2010 7:09:31 AM

Subject: Re: Anabolic steroids- where are the bodies.

Ralph,

What data do you have to back that statement up on suicides?

Evidently, you have yet to find the bodies. So, either they aren't there or you

don't know where to look. Which is it?

Kenny Croxdale

Rio Rancho, NM

Re: Anabolic steroids- where are the bodies.

A common refrain amongst apologists for anabolic steroids is : Where are the

bodies? The bodies are in the cemetary ony the death certificated does not

state they died from steroids. The most likely cause of death heart disease.

It might be cardiac arrhythmia or acute MI.

There is an excellent article in the American Journal of Cardiology which

reviews A total of 49 studies describing 1,467 athletes were reviewed to

investigate the cardiovascular effects of the abuse of AAS.

It cites 99 articles covering this topic. If you are interested in this topic

go to your local hospital Library and check out :

Cardiac and Metabolic Effects of Anabolic-Androgenic Steroid Abuse on Lipids,

Blood Pressure, Left Ventricular Dimensions, and

Rhythm

The American Journal of Cardiology - Volume 106, Issue 6 (September 2010) -

Copyright © 2010 The American College of Cardiology -

Because of copyright and space I cannot put the article here but I have taken

the time to excerpt some of the information I thought might be pertinent along

with the articles or journals cited.

You are not likely to find these studies in your typical muscle magazine or

website. Some of these studies date back to the mid 80s and 90s. The

information is not new just conveniently ignored.

***********************

Cardiac and Metabolic Effects of Anabolic-Androgenic Steroid Abuse on Lipids,

Blood Pressure, Left Ventricular Dimensions, and Rhythm

The American Journal of Cardiology - Volume 106, Issue 6 (September 2010) -

Copyright © 2010 The American College of Cardiology -

AAS and abnormal plasma lipoproteins

AAS abuse has been linked with abnormal plasma lipoproteins (Table 1). Several

studies suggest that AAS abuse in athletes increase low-density lipoprotein

(LDL)

levels by >20% [14] , [36] , [37] , [38] and decrease high-density lipoprotein

(HDL) levels by 20% to 70%. [13] , [14] , [37] , [39] , [40] , [41] , [42] ,

[43] , [44]

By some estimates, these lipoprotein abnormalities increase

the risk for coronary artery disease by three- to sixfold. [14] , [45]

13 Sader M.A., Griffiths K.A., McCredie R.J., Handelsman D.J., Celermajer

D.S.: Androgenic anabolic steroids and arterial structure and function in male

bodybuilders. J Am Coll Cardiol 37. 224-230.2001; Abstract

14 Lenders J.W., Demacker P.N., Vos J.A., Jansen P.L., Hoitsma A.J., Van't Laar

A., Thien T.: Deleterious effects of anabolic steroids on serum lipoproteins,

blood

pressure, and liver function in amateur bodybuilders. Int J Sports Med 9.

19-23.1988; Abstrac

36 Lajarin F., Zaragoza R., r I., ez- P.: Evolution of

serum lipids in two male bodybuilders using anabolic steroids. Clin Chem 42.

970-

972.1996; Abstract

37 McKillop G., Ballantyne D.: Lipoprotein analysis in bodybuilders. Int J

Cardiol 17. 281-288.1987; Abstract

38 Palatini P., Giada F., Garavelli G., Sinisi F., L., Michieletto M.,

Baldo-Enzi G.: Cardiovascular effects of anabolic steroids in weight-trained

subjects. J Clin

Pharmacol 36. 1132-1140.1996; Abstract

39 Baldo-Enzi G., Giada F., Zuliani G., Baroni L., Vitale E., Enzi G.,

Magnanini P., Fellin R.: Lipid and apoprotein modifications in body builders

during and after self-

administration of anabolic steroids. Metabolism 39. 203-208.1990; Abstract

40 Fröhlich J., Kullmer T., Urhausen A., Bergmann R., Kindermann W.: Lipid

profile of body builders with and without self-administration of anabolic

steroids. Eur J

Appl Physiol 59. 98-103.1989; 41 Hartgens F., Rietjens G., K

41 Hartgens F., Rietjens G., Keizer H.A., Kuipers H., Wolffenbuttel B.:

Effects of androgenic-anabolic steroids on apolipoproteins and lipoprotein (a).

Br J Sport

Med 38. 253-259.2004;

42 Lane H., Grace F., J.C., K., Cockcroft J., Scanlon M.F., Davies

J.S.: Impaired vasoreactivity in bodybuilders using androgenic anabolic

steroids. Eur J

Clin Invest 36. 483-488.2006; Abstract

43 Urhausen A., Albers T., Kindermann W.: Are the cardiac effects of anabolic

steroid abuse in strength athletes reversible?. Heart 90. 496-501.2004;

Abstract

44 Zuliani U., Bernardini B., Catapano A., Campana M., Cerioli G., Spattini

M.: Effects of anabolic steroids, testosterone, and HGH on blood lipids and

echocardiographic parameteres in body builders. Int J Sports Med 10.

62-66.1989; Abstract

45 Glazer G.: Atherogenic effects of anabolic steroids on serum lipid levels.

A literature reviewArch Intern Med 151. 1925-1933.1991; Abstract

AAS, acute MI, and sudden death

Alarming data have linked AAS with fatal events, although these are mostly

case-control studies and case reports of acute coronary syndromes, MIs, and

ventricular

arrhythmias. [24] , [46] , [83] , [84] , [85] , [86] , [87] , [88]

88 Fineschi V., Riezzo I., Centini F., Silingardi E., Licata M., Beduschi G.,

Karch S.B.: Sudden cardiac death during anabolic steroid abuse: morphologic and

toxicologic findings in two fatal cases of bodybuilders. Int J Legal Med 121.

48-53.2007; Abstract

89 Sullivan M.L., ez C.M., Gennis P., Gallagher E.J.: The cardiac

toxicity of anabolic steroids. Prog Cardiovasc Dis 41. 1-15.1998; Abstract

90 Ferenchick G.: Anabolic/androgenic steroid abuse and thrombosis: is there a

connection?. Med Hypotheses 35. 27-31.1991; Abstract

91 Roeggia M., Heinz G., Werba E., Roeggla G.: Cardiac tamponade in a

21-year-old body builder with anabolica abuse. Br J Clin Pract 50.

411-412.1996; Citation

92 Ferenchick G., Adelman S.: Myocardial infarction associated with anabolic

steroid use in a previously healthy 37-year-old weight lifter. Am Heart J 124.

507-

508.1992; Citation

93 Huie M.: An acute myocardial infarction occurring in an anabolic steroid

user. Med Sci Sport Exer 26. 408-413.1994;

94 Fisher M., Appleby M., Rittoo D., Cotter L.: Myocardial infarction with

extensive intracoronary thrombus induced by anabolic steroids. Br J Clin Pract

50. 222-

223.1996; Abstract

a postmortem study of male Caucasian AAS abusers (aged 20 to 45 years) suggested

primary cardiac pathology in 1/3, [23]

23 Thiblin I., Lindquist O., Rajs J.: Cause and manner of death among users of

anabolic androgenic steroids. J Forensic Sci 45. 16-23.2000; Abstract

recent case-control study [24] , [25] suggested cardiac causes in 2/3 of deaths,

with others being attributed to suicide, hepatic coma, and malignancy.

24 Parssinen M., Kujala U., Vartiainen E., Sarna S., Seppala T.: Increased

premature mortality of competitive powerlifters suspected to have used anabolic

agents. Int J Sports Med 21. 225-227.2000; Abstrac

25 Parssinen M., Seppala T.: Steroid use and long-term health risks in former

athletes. Sports Med 2002. 83-84.2002; 2

Hausmann et al [84] describe a 23-year-old male bodybuilder who abused AAS and

experienced sudden cardiac arrest. Postmortem examination revealed ventricular

hypertrophy, myocardial fibrosis, and acute MI, and the cause of death was

attributed to arrhythmic sudden death secondary to AAS abuse.

84 Hausmann R., Hammer S., Betz P.: Performance enhancing drugs (doping agents)

and sudden death—a case report and review of the literature. Int J Legal Med

111. 261-264.1998; Abstrac

McNutt et al[46] reported an acute MI in a 22-year-old bodybuilder who admitted

to AAS abuse but lacked cardiac risk factors. The patient presented with

markedly elevated LDL (596 mg/dl) and depressed HDL (14 mg/dl) yet had no family

history of premature atherosclerosis or cardiac events. Within a month of

discontinuing AAS, his LDL decreased to 220 mg/dl and his HDL increased to 35

mg/dl.

46 McNutt R.A., Ferenchick G.S., Kirlin P.C., Hamlin N.J.: Acute myocardial

infarction in a 22-year-old world class weight lifter using anabolic steroids.

Am J Cardiol62.164.1988; Citation

49 Bowman S.: Anabolic steroids and infarction. BMJ 300. 750.1990; Citation

Figure 1 shows the presenting electrocardiogram of a 25-year-old male athlete

who abused nandrolone and presented with an acute MI without traditional cardiac

risk factors. Acute angiography revealed extensive left anterior descending

coronary artery thrombosis, which was managed by thrombolysis. Angiography in

the subacute phase confirmed very mild luminal irregularity at the site of

previous thrombosis.

69 Kennedy C.: Myocardial infarction in association with misuse of anabolic

steroids. Ulster Med J 62. 174-176.1993; Citation

The most commonly observed arrhythmias, typically occurring during physical

exertion, include atrial fibrillation, ventricular fibrillation, ventricular

tachycardia, and supraventricular and ventricular ectopic beats. [95]

95 Furlanello F., Serdoz L.V., Cappato R., De Ambroggi L.: Illicit drugs and

cardiac arrhythmias in athletes. Eur J Cardiovasc Prev Rehabil 14. 487-494.2007;

Abstract

Dickerman et al [96] reported a 20-year-old male bodybuilder who

self-administered AAS 700 mg/week and had sudden cardiac arrest. Autopsy

indicated LVH with a cardiac mass >2 times the upper limit of normal.

96 Dickerman R.D., Schaller F., Prather I., McConathy W.J.: Sudden cardiac death

in a 20-year-old bodybuilder using anabolic steroids. Cardiology 86.

172-173.1995; Abstract

******************

Ralph Giarnella MD

Southington Ct. USA

Posted

I always chuckle when I read these posts about AAS usage and that the bodies are

there if you look for them. I am certainly not an apologist for the usage of

steroids, but I'm not a basher either.

 

If my competitive clientele use them at the risk of failing a drug test that is

their business. I only ask that they disclose this to me so I can adjust the

training. However, I do counsel them that I offer other options to raise

testosterone without the negative effects.

 

When, in my opinion, you look at the big picture though, certain drugs

introduced to the body on a regular short or long-term basis (including

prescription drugs) run the risk of a variety of side effects.

 

Are some of those bodies... broken down, have chronic conditions and have passed

due to steroid usage? Absolutely! But, what about " street drugs " or the abuse of

pain medications?

 

How will one ever be able to actually make a definitive statement?

 

On a closing and much more positive note...I wish all of you a very Happy

Holiday Season. I don't post much, but I read frequently. I appreciate all of

your posts!

 

Best,

Mark Cotton

New Jersey, USA

From: KennyCrox@... <KennyCrox@...>

Subject: Re: Anabolic steroids- where are the bodies.

Supertraining , ragiarn@...

Date: Wednesday, December 22, 2010, 7:09 AM

 

Ralph,

What data do you have to back that statement up on suicides?

Evidently, you have yet to find the bodies. So, either they aren't there or you

don't know where to look. Which is it?

Kenny Croxdale

Rio Rancho, NM

Re: Anabolic steroids- where are the bodies.

The article only looked at cardiac effects of AAS. There is an alarming number

of suicides, amongst AAS users. The bodies are there if you just look for

them.

Ralph Giarnella MD

Southington Ct. USA

Posted

One of my graduate students is gathering longevity data on athletes who threw

the discus, shot, and hammer between 1960 and 1985. We are attempting to catalog

the status of the top 25 athletes in each event for those years. Any information

or advice would be appreciated.

Tom Fahey

Dept of Kinesiology

California State University, Chico

Chico, CA 95929-0330

Re: Anabolic steroids- where are the bodies.

A common refrain amongst apologists for anabolic steroids is : Where are the

bodies? The bodies are in the cemetary ony the death certificated does not

state they died from steroids. The most likely cause of death heart disease.

It might be cardiac arrhythmia or acute MI.

There is an excellent article in the American Journal of Cardiology which

reviews A total of 49 studies describing 1,467 athletes were reviewed to

investigate the cardiovascular effects of the abuse of AAS.

It cites 99 articles covering this topic. If you are interested in this topic

go to your local hospital Library and check out :

Cardiac and Metabolic Effects of Anabolic-Androgenic Steroid Abuse on Lipids,

Blood Pressure, Left Ventricular Dimensions, and

Rhythm

The American Journal of Cardiology - Volume 106, Issue 6 (September 2010) -

Copyright © 2010 The American College of Cardiology -

Because of copyright and space I cannot put the article here but I have taken

the time to excerpt some of the information I thought might be pertinent along

with the articles or journals cited.

You are not likely to find these studies in your typical muscle magazine or

website. Some of these studies date back to the mid 80s and 90s. The

information is not new just conveniently ignored.

***********************

Cardiac and Metabolic Effects of Anabolic-Androgenic Steroid Abuse on Lipids,

Blood Pressure, Left Ventricular Dimensions, and Rhythm

The American Journal of Cardiology - Volume 106, Issue 6 (September 2010) -

Copyright © 2010 The American College of Cardiology -

AAS and abnormal plasma lipoproteins

AAS abuse has been linked with abnormal plasma lipoproteins (Table 1). Several

studies suggest that AAS abuse in athletes increase low-density lipoprotein

(LDL)

levels by >20% [14] , [36] , [37] , [38] and decrease high-density lipoprotein

(HDL) levels by 20% to 70%. [13] , [14] , [37] , [39] , [40] , [41] , [42] ,

[43] , [44]

By some estimates, these lipoprotein abnormalities increase

the risk for coronary artery disease by three- to sixfold. [14] , [45]

13 Sader M.A., Griffiths K.A., McCredie R.J., Handelsman D.J., Celermajer

D.S.: Androgenic anabolic steroids and arterial structure and function in male

bodybuilders. J Am Coll Cardiol 37. 224-230.2001; Abstract

14 Lenders J.W., Demacker P.N., Vos J.A., Jansen P.L., Hoitsma A.J., Van't Laar

A., Thien T.: Deleterious effects of anabolic steroids on serum lipoproteins,

blood

pressure, and liver function in amateur bodybuilders. Int J Sports Med 9.

19-23.1988; Abstrac

36 Lajarin F., Zaragoza R., r I., ez- P.: Evolution of

serum lipids in two male bodybuilders using anabolic steroids. Clin Chem 42.

970-

972.1996; Abstract

37 McKillop G., Ballantyne D.: Lipoprotein analysis in bodybuilders. Int J

Cardiol 17. 281-288.1987; Abstract

38 Palatini P., Giada F., Garavelli G., Sinisi F., L., Michieletto M.,

Baldo-Enzi G.: Cardiovascular effects of anabolic steroids in weight-trained

subjects. J Clin

Pharmacol 36. 1132-1140.1996; Abstract

39 Baldo-Enzi G., Giada F., Zuliani G., Baroni L., Vitale E., Enzi G.,

Magnanini P., Fellin R.: Lipid and apoprotein modifications in body builders

during and after self-

administration of anabolic steroids. Metabolism 39. 203-208.1990; Abstract

40 Fröhlich J., Kullmer T., Urhausen A., Bergmann R., Kindermann W.: Lipid

profile of body builders with and without self-administration of anabolic

steroids. Eur J

Appl Physiol 59. 98-103.1989; 41 Hartgens F., Rietjens G., K

41 Hartgens F., Rietjens G., Keizer H.A., Kuipers H., Wolffenbuttel B.:

Effects of androgenic-anabolic steroids on apolipoproteins and lipoprotein (a).

Br J Sport

Med 38. 253-259.2004;

42 Lane H., Grace F., J.C., K., Cockcroft J., Scanlon M.F., Davies

J.S.: Impaired vasoreactivity in bodybuilders using androgenic anabolic

steroids. Eur J

Clin Invest 36. 483-488.2006; Abstract

43 Urhausen A., Albers T., Kindermann W.: Are the cardiac effects of anabolic

steroid abuse in strength athletes reversible?. Heart 90. 496-501.2004;

Abstract

44 Zuliani U., Bernardini B., Catapano A., Campana M., Cerioli G., Spattini

M.: Effects of anabolic steroids, testosterone, and HGH on blood lipids and

echocardiographic parameteres in body builders. Int J Sports Med 10.

62-66.1989; Abstract

45 Glazer G.: Atherogenic effects of anabolic steroids on serum lipid levels.

A literature reviewArch Intern Med 151. 1925-1933.1991; Abstract

AAS, acute MI, and sudden death

Alarming data have linked AAS with fatal events, although these are mostly

case-control studies and case reports of acute coronary syndromes, MIs, and

ventricular

arrhythmias. [24] , [46] , [83] , [84] , [85] , [86] , [87] , [88]

88 Fineschi V., Riezzo I., Centini F., Silingardi E., Licata M., Beduschi G.,

Karch S.B.: Sudden cardiac death during anabolic steroid abuse: morphologic and

toxicologic findings in two fatal cases of bodybuilders. Int J Legal Med 121.

48-53.2007; Abstract

89 Sullivan M.L., ez C.M., Gennis P., Gallagher E.J.: The cardiac

toxicity of anabolic steroids. Prog Cardiovasc Dis 41. 1-15.1998; Abstract

90 Ferenchick G.: Anabolic/androgenic steroid abuse and thrombosis: is there a

connection?. Med Hypotheses 35. 27-31.1991; Abstract

91 Roeggia M., Heinz G., Werba E., Roeggla G.: Cardiac tamponade in a

21-year-old body builder with anabolica abuse. Br J Clin Pract 50.

411-412.1996; Citation

92 Ferenchick G., Adelman S.: Myocardial infarction associated with anabolic

steroid use in a previously healthy 37-year-old weight lifter. Am Heart J 124.

507-

508.1992; Citation

93 Huie M.: An acute myocardial infarction occurring in an anabolic steroid

user. Med Sci Sport Exer 26. 408-413.1994;

94 Fisher M., Appleby M., Rittoo D., Cotter L.: Myocardial infarction with

extensive intracoronary thrombus induced by anabolic steroids. Br J Clin Pract

50. 222-

223.1996; Abstract

a postmortem study of male Caucasian AAS abusers (aged 20 to 45 years) suggested

primary cardiac pathology in 1/3, [23]

23 Thiblin I., Lindquist O., Rajs J.: Cause and manner of death among users of

anabolic androgenic steroids. J Forensic Sci 45. 16-23.2000; Abstract

recent case-control study [24] , [25] suggested cardiac causes in 2/3 of deaths,

with others being attributed to suicide, hepatic coma, and malignancy.

24 Parssinen M., Kujala U., Vartiainen E., Sarna S., Seppala T.: Increased

premature mortality of competitive powerlifters suspected to have used anabolic

agents. Int J Sports Med 21. 225-227.2000; Abstrac

25 Parssinen M., Seppala T.: Steroid use and long-term health risks in former

athletes. Sports Med 2002. 83-84.2002; 2

Hausmann et al [84] describe a 23-year-old male bodybuilder who abused AAS and

experienced sudden cardiac arrest. Postmortem examination revealed ventricular

hypertrophy, myocardial fibrosis, and acute MI, and the cause of death was

attributed to arrhythmic sudden death secondary to AAS abuse.

84 Hausmann R., Hammer S., Betz P.: Performance enhancing drugs (doping agents)

and sudden death—a case report and review of the literature. Int J Legal Med

111. 261-264.1998; Abstrac

McNutt et al[46] reported an acute MI in a 22-year-old bodybuilder who admitted

to AAS abuse but lacked cardiac risk factors. The patient presented with

markedly elevated LDL (596 mg/dl) and depressed HDL (14 mg/dl) yet had no family

history of premature atherosclerosis or cardiac events. Within a month of

discontinuing AAS, his LDL decreased to 220 mg/dl and his HDL increased to 35

mg/dl.

46 McNutt R.A., Ferenchick G.S., Kirlin P.C., Hamlin N.J.: Acute myocardial

infarction in a 22-year-old world class weight lifter using anabolic steroids.

Am J Cardiol62.164.1988; Citation

49 Bowman S.: Anabolic steroids and infarction. BMJ 300. 750.1990; Citation

Figure 1 shows the presenting electrocardiogram of a 25-year-old male athlete

who abused nandrolone and presented with an acute MI without traditional cardiac

risk factors. Acute angiography revealed extensive left anterior descending

coronary artery thrombosis, which was managed by thrombolysis. Angiography in

the subacute phase confirmed very mild luminal irregularity at the site of

previous thrombosis.

69 Kennedy C.: Myocardial infarction in association with misuse of anabolic

steroids. Ulster Med J 62. 174-176.1993; Citation

The most commonly observed arrhythmias, typically occurring during physical

exertion, include atrial fibrillation, ventricular fibrillation, ventricular

tachycardia, and supraventricular and ventricular ectopic beats. [95]

95 Furlanello F., Serdoz L.V., Cappato R., De Ambroggi L.: Illicit drugs and

cardiac arrhythmias in athletes. Eur J Cardiovasc Prev Rehabil 14. 487-494.2007;

Abstract

Dickerman et al [96] reported a 20-year-old male bodybuilder who

self-administered AAS 700 mg/week and had sudden cardiac arrest. Autopsy

indicated LVH with a cardiac mass >2 times the upper limit of normal.

96 Dickerman R.D., Schaller F., Prather I., McConathy W.J.: Sudden cardiac death

in a 20-year-old bodybuilder using anabolic steroids. Cardiology 86.

172-173.1995; Abstract

******************

Ralph Giarnella MD

Southington Ct. USA

Posted

Ralph,

You apparently can come up with defenitive data.

Drug abuse of any medication cause health issues or leads you down the road to a

quick demise.

Drinking too my water will kill you, hyponatramia.

There is plenty of data form medical experts and the federal government that

counter your statements. Here a quick look at some of it.

http://www.youtube.com/watch?v=z0LEj8IPHGU & feature=related

I will be more than happy to provide with a plethra of data that refutes what

you've presented.

With that said, I am a proponent of just tell the truth and let the chips

fall...

Kenny Croxdale

Rio Rancho, NM

Re: Anabolic steroids- where are the bodies.

A common refrain amongst apologists for anabolic steroids is : Where are the

bodies? The bodies are in the cemetary ony the death certificated does not

state they died from steroids. The most likely cause of death heart disease.

It might be cardiac arrhythmia or acute MI.

There is an excellent article in the American Journal of Cardiology which

reviews A total of 49 studies describing 1,467 athletes were reviewed to

investigate the cardiovascular effects of the abuse of AAS.

It cites 99 articles covering this topic. If you are interested in this topic

go to your local hospital Library and check out :

Cardiac and Metabolic Effects of Anabolic-Androgenic Steroid Abuse on Lipids,

Blood Pressure, Left Ventricular Dimensions, and

Rhythm

The American Journal of Cardiology - Volume 106, Issue 6 (September 2010) -

Copyright © 2010 The American College of Cardiology -

Because of copyright and space I cannot put the article here but I have taken

the time to excerpt some of the information I thought might be pertinent along

with the articles or journals cited.

You are not likely to find these studies in your typical muscle magazine or

website. Some of these studies date back to the mid 80s and 90s. The

information is not new just conveniently ignored.

***********************

Cardiac and Metabolic Effects of Anabolic-Androgenic Steroid Abuse on Lipids,

Blood Pressure, Left Ventricular Dimensions, and Rhythm

The American Journal of Cardiology - Volume 106, Issue 6 (September 2010) -

Copyright © 2010 The American College of Cardiology -

AAS and abnormal plasma lipoproteins

AAS abuse has been linked with abnormal plasma lipoproteins (Table 1). Several

studies suggest that AAS abuse in athletes increase low-density lipoprotein

(LDL)

levels by >20% [14] , [36] , [37] , [38] and decrease high-density lipoprotein

(HDL) levels by 20% to 70%. [13] , [14] , [37] , [39] , [40] , [41] , [42] ,

[43] , [44]

By some estimates, these lipoprotein abnormalities increase

the risk for coronary artery disease by three- to sixfold. [14] , [45]

13 Sader M.A., Griffiths K.A., McCredie R.J., Handelsman D.J., Celermajer

D.S.: Androgenic anabolic steroids and arterial structure and function in male

bodybuilders. J Am Coll Cardiol 37. 224-230.2001; Abstract

14 Lenders J.W., Demacker P.N., Vos J.A., Jansen P.L., Hoitsma A.J., Van't Laar

A., Thien T.: Deleterious effects of anabolic steroids on serum lipoproteins,

blood

pressure, and liver function in amateur bodybuilders. Int J Sports Med 9.

19-23.1988; Abstrac

36 Lajarin F., Zaragoza R., r I., ez- P.: Evolution of

serum lipids in two male bodybuilders using anabolic steroids. Clin Chem 42.

970-

972.1996; Abstract

37 McKillop G., Ballantyne D.: Lipoprotein analysis in bodybuilders. Int J

Cardiol 17. 281-288.1987; Abstract

38 Palatini P., Giada F., Garavelli G., Sinisi F., L., Michieletto M.,

Baldo-Enzi G.: Cardiovascular effects of anabolic steroids in weight-trained

subjects. J Clin

Pharmacol 36. 1132-1140.1996; Abstract

39 Baldo-Enzi G., Giada F., Zuliani G., Baroni L., Vitale E., Enzi G.,

Magnanini P., Fellin R.: Lipid and apoprotein modifications in body builders

during and after self-

administration of anabolic steroids. Metabolism 39. 203-208.1990; Abstract

40 Fröhlich J., Kullmer T., Urhausen A., Bergmann R., Kindermann W.: Lipid

profile of body builders with and without self-administration of anabolic

steroids. Eur J

Appl Physiol 59. 98-103.1989; 41 Hartgens F., Rietjens G., K

41 Hartgens F., Rietjens G., Keizer H.A., Kuipers H., Wolffenbuttel B.:

Effects of androgenic-anabolic steroids on apolipoproteins and lipoprotein (a).

Br J Sport

Med 38. 253-259.2004;

42 Lane H., Grace F., J.C., K., Cockcroft J., Scanlon M.F., Davies

J.S.: Impaired vasoreactivity in bodybuilders using androgenic anabolic

steroids. Eur J

Clin Invest 36. 483-488.2006; Abstract

43 Urhausen A., Albers T., Kindermann W.: Are the cardiac effects of anabolic

steroid abuse in strength athletes reversible?. Heart 90. 496-501.2004;

Abstract

44 Zuliani U., Bernardini B., Catapano A., Campana M., Cerioli G., Spattini

M.: Effects of anabolic steroids, testosterone, and HGH on blood lipids and

echocardiographic parameteres in body builders. Int J Sports Med 10.

62-66.1989; Abstract

45 Glazer G.: Atherogenic effects of anabolic steroids on serum lipid levels.

A literature reviewArch Intern Med 151. 1925-1933.1991; Abstract

AAS, acute MI, and sudden death

Alarming data have linked AAS with fatal events, although these are mostly

case-control studies and case reports of acute coronary syndromes, MIs, and

ventricular

arrhythmias. [24] , [46] , [83] , [84] , [85] , [86] , [87] , [88]

88 Fineschi V., Riezzo I., Centini F., Silingardi E., Licata M., Beduschi G.,

Karch S.B.: Sudden cardiac death during anabolic steroid abuse: morphologic and

toxicologic findings in two fatal cases of bodybuilders. Int J Legal Med 121.

48-53.2007; Abstract

89 Sullivan M.L., ez C.M., Gennis P., Gallagher E.J.: The cardiac

toxicity of anabolic steroids. Prog Cardiovasc Dis 41. 1-15.1998; Abstract

90 Ferenchick G.: Anabolic/androgenic steroid abuse and thrombosis: is there a

connection?. Med Hypotheses 35. 27-31.1991; Abstract

91 Roeggia M., Heinz G., Werba E., Roeggla G.: Cardiac tamponade in a

21-year-old body builder with anabolica abuse. Br J Clin Pract 50.

411-412.1996; Citation

92 Ferenchick G., Adelman S.: Myocardial infarction associated with anabolic

steroid use in a previously healthy 37-year-old weight lifter. Am Heart J 124.

507-

508.1992; Citation

93 Huie M.: An acute myocardial infarction occurring in an anabolic steroid

user. Med Sci Sport Exer 26. 408-413.1994;

94 Fisher M., Appleby M., Rittoo D., Cotter L.: Myocardial infarction with

extensive intracoronary thrombus induced by anabolic steroids. Br J Clin Pract

50. 222-

223.1996; Abstract

a postmortem study of male Caucasian AAS abusers (aged 20 to 45 years) suggested

primary cardiac pathology in 1/3, [23]

23 Thiblin I., Lindquist O., Rajs J.: Cause and manner of death among users of

anabolic androgenic steroids. J Forensic Sci 45. 16-23.2000; Abstract

recent case-control study [24] , [25] suggested cardiac causes in 2/3 of deaths,

with others being attributed to suicide, hepatic coma, and malignancy.

24 Parssinen M., Kujala U., Vartiainen E., Sarna S., Seppala T.: Increased

premature mortality of competitive powerlifters suspected to have used anabolic

agents. Int J Sports Med 21. 225-227.2000; Abstrac

25 Parssinen M., Seppala T.: Steroid use and long-term health risks in former

athletes. Sports Med 2002. 83-84.2002; 2

Hausmann et al [84] describe a 23-year-old male bodybuilder who abused AAS and

experienced sudden cardiac arrest. Postmortem examination revealed ventricular

hypertrophy, myocardial fibrosis, and acute MI, and the cause of death was

attributed to arrhythmic sudden death secondary to AAS abuse.

84 Hausmann R., Hammer S., Betz P.: Performance enhancing drugs (doping agents)

and sudden death—a case report and review of the literature. Int J Legal Med

111. 261-264.1998; Abstrac

McNutt et al[46] reported an acute MI in a 22-year-old bodybuilder who admitted

to AAS abuse but lacked cardiac risk factors. The patient presented with

markedly elevated LDL (596 mg/dl) and depressed HDL (14 mg/dl) yet had no family

history of premature atherosclerosis or cardiac events. Within a month of

discontinuing AAS, his LDL decreased to 220 mg/dl and his HDL increased to 35

mg/dl.

46 McNutt R.A., Ferenchick G.S., Kirlin P.C., Hamlin N.J.: Acute myocardial

infarction in a 22-year-old world class weight lifter using anabolic steroids.

Am J Cardiol62.164.1988; Citation

49 Bowman S.: Anabolic steroids and infarction. BMJ 300. 750.1990; Citation

Figure 1 shows the presenting electrocardiogram of a 25-year-old male athlete

who abused nandrolone and presented with an acute MI without traditional cardiac

risk factors. Acute angiography revealed extensive left anterior descending

coronary artery thrombosis, which was managed by thrombolysis. Angiography in

the subacute phase confirmed very mild luminal irregularity at the site of

previous thrombosis.

69 Kennedy C.: Myocardial infarction in association with misuse of anabolic

steroids. Ulster Med J 62. 174-176.1993; Citation

The most commonly observed arrhythmias, typically occurring during physical

exertion, include atrial fibrillation, ventricular fibrillation, ventricular

tachycardia, and supraventricular and ventricular ectopic beats. [95]

95 Furlanello F., Serdoz L.V., Cappato R., De Ambroggi L.: Illicit drugs and

cardiac arrhythmias in athletes. Eur J Cardiovasc Prev Rehabil 14. 487-494.2007;

Abstract

Dickerman et al [96] reported a 20-year-old male bodybuilder who

self-administered AAS 700 mg/week and had sudden cardiac arrest. Autopsy

indicated LVH with a cardiac mass >2 times the upper limit of normal.

96 Dickerman R.D., Schaller F., Prather I., McConathy W.J.: Sudden cardiac death

in a 20-year-old bodybuilder using anabolic steroids. Cardiology 86.

172-173.1995; Abstract

******************

Ralph Giarnella MD

Southington Ct. USA

Posted

Tom, I was thinking about you when preparing my post on anabolic steroids. I

believe that you made a comment in a post within the last two years concerning

early deaths amongst athletes you knew and who were taking steroids. Perhaps

you can comment on this topic.

Ralph Giarnella MD

Southington Ct. USA

________________________________

From: Tom Fahey <discusdoc@...>

Supertraining

Cc: tp_soccer3@...

Sent: Wed, December 22, 2010 9:35:33 AM

Subject: Re: Anabolic steroids- where are the bodies.

One of my graduate students is gathering longevity data on athletes who threw

the discus, shot, and hammer between 1960 and 1985. We are attempting to catalog

the status of the top 25 athletes in each event for those years. Any information

or advice would be appreciated.

Tom Fahey

Dept of Kinesiology

California State University, Chico

Chico, CA 95929-0330

Re: Anabolic steroids- where are the bodies.

A common refrain amongst apologists for anabolic steroids is : Where are the

bodies? The bodies are in the cemetary ony the death certificated does not

state they died from steroids. The most likely cause of death heart disease.

It might be cardiac arrhythmia or acute MI.

There is an excellent article in the American Journal of Cardiology which

reviews A total of 49 studies describing 1,467 athletes were reviewed to

investigate the cardiovascular effects of the abuse of AAS.

It cites 99 articles covering this topic. If you are interested in this topic

go to your local hospital Library and check out :

Cardiac and Metabolic Effects of Anabolic-Androgenic Steroid Abuse on Lipids,

Blood Pressure, Left Ventricular Dimensions, and

Rhythm

The American Journal of Cardiology - Volume 106, Issue 6 (September 2010) -

Copyright © 2010 The American College of Cardiology -

Because of copyright and space I cannot put the article here but I have taken

the time to excerpt some of the information I thought might be pertinent along

with the articles or journals cited.

You are not likely to find these studies in your typical muscle magazine or

website. Some of these studies date back to the mid 80s and 90s. The

information is not new just conveniently ignored.

***********************

Cardiac and Metabolic Effects of Anabolic-Androgenic Steroid Abuse on Lipids,

Blood Pressure, Left Ventricular Dimensions, and Rhythm

The American Journal of Cardiology - Volume 106, Issue 6 (September 2010) -

Copyright © 2010 The American College of Cardiology -

AAS and abnormal plasma lipoproteins

AAS abuse has been linked with abnormal plasma lipoproteins (Table 1). Several

studies suggest that AAS abuse in athletes increase low-density lipoprotein

(LDL)

levels by >20% [14] , [36] , [37] , [38] and decrease high-density lipoprotein

(HDL) levels by 20% to 70%. [13] , [14] , [37] , [39] , [40] , [41] , [42] ,

[43] , [44]

By some estimates, these lipoprotein abnormalities increase

the risk for coronary artery disease by three- to sixfold. [14] , [45]

13 Sader M.A., Griffiths K.A., McCredie R.J., Handelsman D.J., Celermajer

D.S.: Androgenic anabolic steroids and arterial structure and function in male

bodybuilders. J Am Coll Cardiol 37. 224-230.2001; Abstract

14 Lenders J.W., Demacker P.N., Vos J.A., Jansen P.L., Hoitsma A.J., Van't Laar

A., Thien T.: Deleterious effects of anabolic steroids on serum lipoproteins,

blood

pressure, and liver function in amateur bodybuilders. Int J Sports Med 9.

19-23.1988; Abstrac

36 Lajarin F., Zaragoza R., r I., ez- P.: Evolution of

serum lipids in two male bodybuilders using anabolic steroids. Clin Chem 42.

970-

972.1996; Abstract

37 McKillop G., Ballantyne D.: Lipoprotein analysis in bodybuilders. Int J

Cardiol 17. 281-288.1987; Abstract

38 Palatini P., Giada F., Garavelli G., Sinisi F., L., Michieletto M.,

Baldo-Enzi G.: Cardiovascular effects of anabolic steroids in weight-trained

subjects. J Clin

Pharmacol 36. 1132-1140.1996; Abstract

39 Baldo-Enzi G., Giada F., Zuliani G., Baroni L., Vitale E., Enzi G.,

Magnanini P., Fellin R.: Lipid and apoprotein modifications in body builders

during and after self-

administration of anabolic steroids. Metabolism 39. 203-208.1990; Abstract

40 Fröhlich J., Kullmer T., Urhausen A., Bergmann R., Kindermann W.: Lipid

profile of body builders with and without self-administration of anabolic

steroids. Eur J

Appl Physiol 59. 98-103.1989; 41 Hartgens F., Rietjens G., K

41 Hartgens F., Rietjens G., Keizer H.A., Kuipers H., Wolffenbuttel B.:

Effects of androgenic-anabolic steroids on apolipoproteins and lipoprotein (a).

Br J Sport

Med 38. 253-259.2004;

42 Lane H., Grace F., J.C., K., Cockcroft J., Scanlon M.F., Davies

J.S.: Impaired vasoreactivity in bodybuilders using androgenic anabolic

steroids. Eur J

Clin Invest 36. 483-488.2006; Abstract

43 Urhausen A., Albers T., Kindermann W.: Are the cardiac effects of anabolic

steroid abuse in strength athletes reversible?. Heart 90. 496-501.2004;

Abstract

44 Zuliani U., Bernardini B., Catapano A., Campana M., Cerioli G., Spattini

M.: Effects of anabolic steroids, testosterone, and HGH on blood lipids and

echocardiographic parameteres in body builders. Int J Sports Med 10.

62-66.1989; Abstract

45 Glazer G.: Atherogenic effects of anabolic steroids on serum lipid levels.

A literature reviewArch Intern Med 151. 1925-1933.1991; Abstract

AAS, acute MI, and sudden death

Alarming data have linked AAS with fatal events, although these are mostly

case-control studies and case reports of acute coronary syndromes, MIs, and

ventricular

arrhythmias. [24] , [46] , [83] , [84] , [85] , [86] , [87] , [88]

88 Fineschi V., Riezzo I., Centini F., Silingardi E., Licata M., Beduschi G.,

Karch S.B.: Sudden cardiac death during anabolic steroid abuse: morphologic and

toxicologic findings in two fatal cases of bodybuilders. Int J Legal Med 121.

48-53.2007; Abstract

89 Sullivan M.L., ez C.M., Gennis P., Gallagher E.J.: The cardiac

toxicity of anabolic steroids. Prog Cardiovasc Dis 41. 1-15.1998; Abstract

90 Ferenchick G.: Anabolic/androgenic steroid abuse and thrombosis: is there a

connection?. Med Hypotheses 35. 27-31.1991; Abstract

91 Roeggia M., Heinz G., Werba E., Roeggla G.: Cardiac tamponade in a

21-year-old body builder with anabolica abuse. Br J Clin Pract 50.

411-412.1996; Citation

92 Ferenchick G., Adelman S.: Myocardial infarction associated with anabolic

steroid use in a previously healthy 37-year-old weight lifter. Am Heart J 124.

507-

508.1992; Citation

93 Huie M.: An acute myocardial infarction occurring in an anabolic steroid

user. Med Sci Sport Exer 26. 408-413.1994;

94 Fisher M., Appleby M., Rittoo D., Cotter L.: Myocardial infarction with

extensive intracoronary thrombus induced by anabolic steroids. Br J Clin Pract

50. 222-

223.1996; Abstract

a postmortem study of male Caucasian AAS abusers (aged 20 to 45 years) suggested

primary cardiac pathology in 1/3, [23]

23 Thiblin I., Lindquist O., Rajs J.: Cause and manner of death among users of

anabolic androgenic steroids. J Forensic Sci 45. 16-23.2000; Abstract

recent case-control study [24] , [25] suggested cardiac causes in 2/3 of deaths,

with others being attributed to suicide, hepatic coma, and malignancy.

24 Parssinen M., Kujala U., Vartiainen E., Sarna S., Seppala T.: Increased

premature mortality of competitive powerlifters suspected to have used anabolic

agents. Int J Sports Med 21. 225-227.2000; Abstrac

25 Parssinen M., Seppala T.: Steroid use and long-term health risks in former

athletes. Sports Med 2002. 83-84.2002; 2

Hausmann et al [84] describe a 23-year-old male bodybuilder who abused AAS and

experienced sudden cardiac arrest. Postmortem examination revealed ventricular

hypertrophy, myocardial fibrosis, and acute MI, and the cause of death was

attributed to arrhythmic sudden death secondary to AAS abuse.

84 Hausmann R., Hammer S., Betz P.: Performance enhancing drugs (doping agents)

and sudden death—a case report and review of the literature. Int J Legal Med

111. 261-264.1998; Abstrac

McNutt et al[46] reported an acute MI in a 22-year-old bodybuilder who admitted

to AAS abuse but lacked cardiac risk factors. The patient presented with

markedly elevated LDL (596 mg/dl) and depressed HDL (14 mg/dl) yet had no family

history of premature atherosclerosis or cardiac events. Within a month of

discontinuing AAS, his LDL decreased to 220 mg/dl and his HDL increased to 35

mg/dl.

46 McNutt R.A., Ferenchick G.S., Kirlin P.C., Hamlin N.J.: Acute myocardial

infarction in a 22-year-old world class weight lifter using anabolic steroids.

Am J Cardiol62.164.1988; Citation

49 Bowman S.: Anabolic steroids and infarction. BMJ 300. 750.1990; Citation

Figure 1 shows the presenting electrocardiogram of a 25-year-old male athlete

who abused nandrolone and presented with an acute MI without traditional cardiac

risk factors. Acute angiography revealed extensive left anterior descending

coronary artery thrombosis, which was managed by thrombolysis. Angiography in

the subacute phase confirmed very mild luminal irregularity at the site of

previous thrombosis.

69 Kennedy C.: Myocardial infarction in association with misuse of anabolic

steroids. Ulster Med J 62. 174-176.1993; Citation

The most commonly observed arrhythmias, typically occurring during physical

exertion, include atrial fibrillation, ventricular fibrillation, ventricular

tachycardia, and supraventricular and ventricular ectopic beats. [95]

95 Furlanello F., Serdoz L.V., Cappato R., De Ambroggi L.: Illicit drugs and

cardiac arrhythmias in athletes. Eur J Cardiovasc Prev Rehabil 14. 487-494.2007;

Abstract

Dickerman et al [96] reported a 20-year-old male bodybuilder who

self-administered AAS 700 mg/week and had sudden cardiac arrest. Autopsy

indicated LVH with a cardiac mass >2 times the upper limit of normal.

96 Dickerman R.D., Schaller F., Prather I., McConathy W.J.: Sudden cardiac death

in a 20-year-old bodybuilder using anabolic steroids. Cardiology 86.

172-173.1995; Abstract

******************

Ralph Giarnella MD

Southington Ct. USA

Posted

The variety of side effects of AAS on women though, now there's a bad idea all

around... few prescription drugs for a legal purpose make a woman into a man (at

least take her to the point of just having things well, nipped on in an

operation! or cause sufficient changes to make the gender indistinct?)

I've always said that if a woman has to join the male race to succeed, she's in

the wrong sport. Ok one more thing I've said - just because men feel it's

necessary to take steroids does not mean we ladies need follow them down this

particular path... :)

No offense, but my personal opinion is that it takes a better man to not use the

drugs and succeed.

To thine own self be true.

the Phantom

aka Schaefer, lifetime drug free powerlifter

Denver, Colorado, USA

Re: Anabolic steroids- where are the bodies.

The article only looked at cardiac effects of AAS. There is an alarming number

of suicides, amongst AAS users. The bodies are there if you just look for

them.

Ralph Giarnella MD

Southington Ct. USA

Posted

Kenny, I would appreciate it if you could provide me with scientific data in

peer reviewed journals showing that anabolic steroids used in supraphysioligic

doses are safe. I have yet to see an single scientifi article or study that

valididates the use of suprphysiologic does of AAS.

I had seen the you tube you cited (not a very scientific or credible venue) and

the info is not very convincing and is anecdotal at best.

I gave you studies in which the bodies of real body builders and weight lifters

were studied in detail by scientists. You asked the question in a previous post

" where are the bodies " . I gave you the bodies. Do you have evidence that

refutes the autopsies or denies the validity of the autopsies who those young

men who died because they were convinced that what they were doing was safe.

I think it is important to underline the fact that this discussion concerns

supraphysiologic doses of anabolic steroids and not therapeutic use of

hormones. The topic of therapeutic use requires another discussion.

Ralph Giarnella MD

Southington Ct. USA.

________________________________

From: " KennyCrox@... " <KennyCrox@...>

Supertraining

Sent: Wed, December 22, 2010 12:03:42 PM

Subject: Re: Anabolic steroids- where are the bodies.

Ralph,

You apparently can come up with defenitive data.

Drug abuse of any medication cause health issues or leads you down the road to a

quick demise.

Drinking too my water will kill you, hyponatramia.

There is plenty of data form medical experts and the federal government that

counter your statements. Here a quick look at some of it.

http://www.youtube.com/watch?v=z0LEj8IPHGU & feature=related

I will be more than happy to provide with a plethra of data that refutes what

you've presented.

With that said, I am a proponent of just tell the truth and let the chips

fall...

Kenny Croxdale

Rio Rancho, NM

Re: Anabolic steroids- where are the bodies.

A common refrain amongst apologists for anabolic steroids is : Where are the

bodies? The bodies are in the cemetary ony the death certificated does not

state they died from steroids. The most likely cause of death heart disease.

It might be cardiac arrhythmia or acute MI.

There is an excellent article in the American Journal of Cardiology which

reviews A total of 49 studies describing 1,467 athletes were reviewed to

investigate the cardiovascular effects of the abuse of AAS.

It cites 99 articles covering this topic. If you are interested in this topic

go to your local hospital Library and check out :

Cardiac and Metabolic Effects of Anabolic-Androgenic Steroid Abuse on Lipids,

Blood Pressure, Left Ventricular Dimensions, and

Rhythm

The American Journal of Cardiology - Volume 106, Issue 6 (September 2010) -

Copyright © 2010 The American College of Cardiology -

Because of copyright and space I cannot put the article here but I have taken

the time to excerpt some of the information I thought might be pertinent along

with the articles or journals cited.

You are not likely to find these studies in your typical muscle magazine or

website. Some of these studies date back to the mid 80s and 90s. The

information is not new just conveniently ignored.

***********************

Cardiac and Metabolic Effects of Anabolic-Androgenic Steroid Abuse on Lipids,

Blood Pressure, Left Ventricular Dimensions, and Rhythm

The American Journal of Cardiology - Volume 106, Issue 6 (September 2010) -

Copyright © 2010 The American College of Cardiology -

AAS and abnormal plasma lipoproteins

AAS abuse has been linked with abnormal plasma lipoproteins (Table 1). Several

studies suggest that AAS abuse in athletes increase low-density lipoprotein

(LDL)

levels by >20% [14] , [36] , [37] , [38] and decrease high-density lipoprotein

(HDL) levels by 20% to 70%. [13] , [14] , [37] , [39] , [40] , [41] , [42] ,

[43] , [44]

By some estimates, these lipoprotein abnormalities increase

the risk for coronary artery disease by three- to sixfold. [14] , [45]

13 Sader M.A., Griffiths K.A., McCredie R.J., Handelsman D.J., Celermajer

D.S.: Androgenic anabolic steroids and arterial structure and function in male

bodybuilders. J Am Coll Cardiol 37. 224-230.2001; Abstract

14 Lenders J.W., Demacker P.N., Vos J.A., Jansen P.L., Hoitsma A.J., Van't Laar

A., Thien T.: Deleterious effects of anabolic steroids on serum lipoproteins,

blood

pressure, and liver function in amateur bodybuilders. Int J Sports Med 9.

19-23.1988; Abstrac

36 Lajarin F., Zaragoza R., r I., ez- P.: Evolution of

serum lipids in two male bodybuilders using anabolic steroids. Clin Chem 42.

970-

972.1996; Abstract

37 McKillop G., Ballantyne D.: Lipoprotein analysis in bodybuilders. Int J

Cardiol 17. 281-288.1987; Abstract

38 Palatini P., Giada F., Garavelli G., Sinisi F., L., Michieletto M.,

Baldo-Enzi G.: Cardiovascular effects of anabolic steroids in weight-trained

subjects. J Clin

Pharmacol 36. 1132-1140.1996; Abstract

39 Baldo-Enzi G., Giada F., Zuliani G., Baroni L., Vitale E., Enzi G.,

Magnanini P., Fellin R.: Lipid and apoprotein modifications in body builders

during and after self-

administration of anabolic steroids. Metabolism 39. 203-208.1990; Abstract

40 Fröhlich J., Kullmer T., Urhausen A., Bergmann R., Kindermann W.: Lipid

profile of body builders with and without self-administration of anabolic

steroids. Eur J

Appl Physiol 59. 98-103.1989; 41 Hartgens F., Rietjens G., K

41 Hartgens F., Rietjens G., Keizer H.A., Kuipers H., Wolffenbuttel B.:

Effects of androgenic-anabolic steroids on apolipoproteins and lipoprotein (a).

Br J Sport

Med 38. 253-259.2004;

42 Lane H., Grace F., J.C., K., Cockcroft J., Scanlon M.F., Davies

J.S.: Impaired vasoreactivity in bodybuilders using androgenic anabolic

steroids. Eur J

Clin Invest 36. 483-488.2006; Abstract

43 Urhausen A., Albers T., Kindermann W.: Are the cardiac effects of anabolic

steroid abuse in strength athletes reversible?. Heart 90. 496-501.2004;

Abstract

44 Zuliani U., Bernardini B., Catapano A., Campana M., Cerioli G., Spattini

M.: Effects of anabolic steroids, testosterone, and HGH on blood lipids and

echocardiographic parameteres in body builders. Int J Sports Med 10.

62-66.1989; Abstract

45 Glazer G.: Atherogenic effects of anabolic steroids on serum lipid levels.

A literature reviewArch Intern Med 151. 1925-1933.1991; Abstract

AAS, acute MI, and sudden death

Alarming data have linked AAS with fatal events, although these are mostly

case-control studies and case reports of acute coronary syndromes, MIs, and

ventricular

arrhythmias. [24] , [46] , [83] , [84] , [85] , [86] , [87] , [88]

88 Fineschi V., Riezzo I., Centini F., Silingardi E., Licata M., Beduschi G.,

Karch S.B.: Sudden cardiac death during anabolic steroid abuse: morphologic and

toxicologic findings in two fatal cases of bodybuilders. Int J Legal Med 121.

48-53.2007; Abstract

89 Sullivan M.L., ez C.M., Gennis P., Gallagher E.J.: The cardiac

toxicity of anabolic steroids. Prog Cardiovasc Dis 41. 1-15.1998; Abstract

90 Ferenchick G.: Anabolic/androgenic steroid abuse and thrombosis: is there a

connection?. Med Hypotheses 35. 27-31.1991; Abstract

91 Roeggia M., Heinz G., Werba E., Roeggla G.: Cardiac tamponade in a

21-year-old body builder with anabolica abuse. Br J Clin Pract 50.

411-412.1996; Citation

92 Ferenchick G., Adelman S.: Myocardial infarction associated with anabolic

steroid use in a previously healthy 37-year-old weight lifter. Am Heart J 124.

507-

508.1992; Citation

93 Huie M.: An acute myocardial infarction occurring in an anabolic steroid

user. Med Sci Sport Exer 26. 408-413.1994;

94 Fisher M., Appleby M., Rittoo D., Cotter L.: Myocardial infarction with

extensive intracoronary thrombus induced by anabolic steroids. Br J Clin Pract

50. 222-

223.1996; Abstract

a postmortem study of male Caucasian AAS abusers (aged 20 to 45 years) suggested

primary cardiac pathology in 1/3, [23]

23 Thiblin I., Lindquist O., Rajs J.: Cause and manner of death among users of

anabolic androgenic steroids. J Forensic Sci 45. 16-23.2000; Abstract

recent case-control study [24] , [25] suggested cardiac causes in 2/3 of deaths,

with others being attributed to suicide, hepatic coma, and malignancy.

24 Parssinen M., Kujala U., Vartiainen E., Sarna S., Seppala T.: Increased

premature mortality of competitive powerlifters suspected to have used anabolic

agents. Int J Sports Med 21. 225-227.2000; Abstrac

25 Parssinen M., Seppala T.: Steroid use and long-term health risks in former

athletes. Sports Med 2002. 83-84.2002; 2

Hausmann et al [84] describe a 23-year-old male bodybuilder who abused AAS and

experienced sudden cardiac arrest. Postmortem examination revealed ventricular

hypertrophy, myocardial fibrosis, and acute MI, and the cause of death was

attributed to arrhythmic sudden death secondary to AAS abuse.

84 Hausmann R., Hammer S., Betz P.: Performance enhancing drugs (doping agents)

and sudden death—a case report and review of the literature. Int J Legal Med

111. 261-264.1998; Abstrac

McNutt et al[46] reported an acute MI in a 22-year-old bodybuilder who admitted

to AAS abuse but lacked cardiac risk factors. The patient presented with

markedly elevated LDL (596 mg/dl) and depressed HDL (14 mg/dl) yet had no family

history of premature atherosclerosis or cardiac events. Within a month of

discontinuing AAS, his LDL decreased to 220 mg/dl and his HDL increased to 35

mg/dl.

46 McNutt R.A., Ferenchick G.S., Kirlin P.C., Hamlin N.J.: Acute myocardial

infarction in a 22-year-old world class weight lifter using anabolic steroids.

Am J Cardiol62.164.1988; Citation

49 Bowman S.: Anabolic steroids and infarction. BMJ 300. 750.1990; Citation

Figure 1 shows the presenting electrocardiogram of a 25-year-old male athlete

who abused nandrolone and presented with an acute MI without traditional cardiac

risk factors. Acute angiography revealed extensive left anterior descending

coronary artery thrombosis, which was managed by thrombolysis. Angiography in

the subacute phase confirmed very mild luminal irregularity at the site of

previous thrombosis.

69 Kennedy C.: Myocardial infarction in association with misuse of anabolic

steroids. Ulster Med J 62. 174-176.1993; Citation

The most commonly observed arrhythmias, typically occurring during physical

exertion, include atrial fibrillation, ventricular fibrillation, ventricular

tachycardia, and supraventricular and ventricular ectopic beats. [95]

95 Furlanello F., Serdoz L.V., Cappato R., De Ambroggi L.: Illicit drugs and

cardiac arrhythmias in athletes. Eur J Cardiovasc Prev Rehabil 14. 487-494.2007;

Abstract

Dickerman et al [96] reported a 20-year-old male bodybuilder who

self-administered AAS 700 mg/week and had sudden cardiac arrest. Autopsy

indicated LVH with a cardiac mass >2 times the upper limit of normal.

96 Dickerman R.D., Schaller F., Prather I., McConathy W.J.: Sudden cardiac death

in a 20-year-old bodybuilder using anabolic steroids. Cardiology 86.

172-173.1995; Abstract

******************

Ralph Giarnella MD

Southington Ct. USA

Posted

I agree with your observations. However the therapeutic use of hormones as

a safe preventive is not totally clear because there are no large long term

studies done.

It must be recalled here that for many yearsHRT for women was not only

considered safe but it was purported to decrease the incidence of heart

disease. I remember attending hospital lectures given by a world renowned

professor of Gynecology touting the cardiac benefits of HRT. He pointed out

that 50% of women died as a result of heart disease and stroke and HRT could

decrease this. He noted that there was no significant increase in cancer of the

breast associated with it suse.

It was only after a large study looking at 10s of thousands of women for a

decade did it become clear that HRT not only increased the risk for cancer in

women who had taken it for a prolonged period but that instead of protecting

them from heart disease it actually increased their risk of cardiovascular

disease. This was while using therapeutic doses of the hormone.

Women felt significantly better on these hormones, were more energetic and

vibrant and even appeared to be younger. However when compared to a group of

women matched for age and not taking HRT over the same time period more of the

women on HRT were dying of cancers and heart disease.

Nowadays HRT for women is used for a short period of time (3-5) years to help

some women overcome the perimenopausal symptoms which can be very dibilitating

for many. It should be noted that it was the long term use that increased the

risk and not the short term risk.

Many a medicine has been shown to safe in limited controlled studies (several

thousand patients) for short period of time (1-2 years) only to be found to

unsafe when it was used by millions. Sometimes it takes a large pool of

individuals to find statistically significant data to show the dangers. Perfect

examples are the widely publicized Vioxx as well as Avandia cases. Both were

shown to be safe in initial small studies. It was not until they were

prescribed to millions that a statisticaly significant increase in deaths

became more evident.

I am not aware of any large (1000s of subjects) double blind controlled (neither

the subject nor the investigator knows who is getting the real pill or the

placebo) long term (5+ years) studies on the safetyo male HRT.

Until such a study is done physicians will be reluctant to hand out

prescriptions for HRT to individuals with levels within acceptable normal

ranges. All it takes are a few wrongful death lawsuits.

Ralph Giarnella MD

Southington Ct. USA

________________________________

From: Casler <bioforce.inc@...>

Supertraining

Sent: Wed, December 22, 2010 11:07:57 AM

Subject: Anabolic steroids- where are the bodies.

Ralph Giarnella MD wrote:

You apparently missed the point of the article. There are numerous case

studies of young weight lifters and body builders who abused AAS and died

and subsequently underwent autopsy. These are individuals who had no other

risk factors for heart disease. When a person dies of heart disease because

of a bad diet the death certificate does not state that they died because

they had a poor diet. It just states they died of a heart attack. Death

certificates do not state that an individual died because of obesity nor

does it state that they died as the result of smoking. Death certificates

list the conditions caused by these conditions such as heart diseasea,

diabetes, emphysema or copd. As a matter of fact in my state (Connecticut)

only recently has there been a box to check off is smoking might have been a

contributing cause of this persons death. There is no box to check for

alcohol abuse, obesity or eating at Mcs. a

There is plenty of science available in the literature concerning the

dangers of AAS, however the AAS apologists conveninetly ignore the science.

Casler writes:

I think it is extremely important to take an informed viewpoint that looks

at all the implications. Anabolic Steroids and other endocrine drugs can be

abused or they can be used. This means don't be an apologist nor an

alarmist regarding the subject.

We also need to disassociate their medical use with the abuse and cheating

usage in sports.

While you can draw associations with cases that may have been caused by

abuse, we should not let that hamper the proper medical use of such

medications to improve health and the quality of life. There is MUCH

evidence that the proper medical use will NOT cause heart and coronary

disease, but it will reduce or prevent it. The hysteria that surrounds

hormonal abuse is likely warranted, but it need be tempered and disconnected

from their positive medical implementation.

Insulin is another hormone more commonly used in a medical sense and is

arguably more anabolic than testosterone. It is also even more dangerous if

abused or used improperly, so I think we need adapt the same viewpoint to

all exogenous hormonal use. Broad brush hand waving creates a strange

phenomenon whereby the " good " that can be done thwarts the amount of

research that needs to be carried out to be truly helpful.

HRT (hormone replacement therapy) is beginning to gain an interest and it

would seem that if the " balancing act " of using the medications properly is

more sophisticated that it will in fact REDUCE cancers, heart disease, sarco

and osteopenia, diabetes, metabolic syndrome, and many other ailments that

manifest (especially) males as they suffer a reduction in testosterone

production.

Enlarged hearts and other heart conditions assigned to steroid abuse may

certainly be true, but years before steroid abuse was around these same

conditions fell many former athletes.

I'm just suggesting not to throw the baby out with the bath water. I think

in the future, if we can get beyond this publicity generated hysteria, so

that endocrine science will advance and health and the quality of life will

be enhanced and improved with greater understanding and implementation.

Just like we now know more about nutrition, and how manipulating our intakes

can be positive, we will likely see that we can also learn how to control

hormonal/endocrine levels to a better and healthier result.

Regards,

Casler

TRI-VECTOR 3-D Training Systems

Century City, CA

-II-----II-

Posted

Casey,

I stated that the Real Sports report with Armen Keteyian (currently with CBS

News) was " a quick look at it " ...that meanint it provided some information on

the subject.

I have some additional in depth documentation on the matter.

As I previously stated, abuse of AAS or for that matter any other medication

will eventually cause problems. Please re-read my post.

Kenny Croxdale, CSCS

Rio Rancho, NM

Re: Anabolic steroids- where are the bodies.

Kenny,

I don't think that an HBO story of steroid use covering what a few people call

the lack of evidence supporting the dangers of using or abusing steroids a

viable counter to the sample of evidence Dr. Ralph is providing, which is the

tip of the iceberg when it comes to research regarding the use and abuse of AAS.

=====================

Posted

Sigh. Without a baseline testosterone on most guys, we've no idea where their

levels were at their peak of health/youth.

Obviously the same applies to women... I know of one good PL gal who had LOW

testosterone - probably in the thinking espoused below, received HRT for her low

test? However it did not affect her lifting, and she was top ranked...

How do we know about her test level? She had to at one point take a blood test

to prove that her levels were not only normal, but actually low...because of a

failed " lie detector " test lol. Got so nervous (the woman does NOT even drink

soda or well, coffee!) that she failed it. Another side issue with those tests

where the nervous innocent get bailed in with the guilty but that's another

topic..

So if a lady in her prime and best lifting days actually comes up clinically low

in testosterone, perhaps some men are also " clinically low " and yet quite

functional and arguably better than " just functional " ? How much of the

testosterone/supplementation is mental/emotional - where is the study PROVING

the efficacy of the usage too? Perhaps a nice double blind with the placebo

effect...? Remember the " Star Trek " episode, " Mudd's Women " ?

Youthful appearance and behavior may be as close as getting a good night's sleep

and taking a day off from the " foxhole economy " right now...the " get your butt

in your chair and keep your head down " stress is aging everyone IMHO! More

chalk, less chair!

Lastly - the argument about " where are the bodies " is the same bs you get from

cigarette smokers - " it's not on the death certificate " . Never mind that well, a

lot of cigarette smokers appear to be plenty dead from usage. Sure, some thrive

on cigs...and likely some thrive on AAS and other less than desired practices?

Putting drinking coffee in this list of items is a red herring. Sorry, but it's

really not the worst practice and might arguably save lives at times lol.

Perhaps such dangers are the lack of coffee, rather than inclusion :).

Thanks for the original posting, Dr. Ralph -

and a Merry (non-AAS/nonWADA violating) Christmas to everyone here :)

The Phantom

aka Schaefer, CMT/RMT, competing powerlifter

Denver, Colorado, USA

Anabolic steroids- where are the bodies.

The Phantom wrote

-

There's also the point of ethics in sport. Cheating is what you're doing if

you breach the rules - and people scream quite loudly when someone say,

breaks a rule on the field, right?

If anything, people need to be less comfy about AAS and other cheats and

perhaps return their thinking to a more level way of viewing ALL cheating as

cheating.

Casler writes:

Hi ,

I agree and haven't suggested supporting cheating in athletic competition in

any way, nor have I suggested that the " abuse " of steroids is positive in

any way. My point is to be careful in the message sent regarding all uses

of exogenous hormones, so that they do not get a broad brush demonization.

The facts of the matter are that one of the key elements to aging, and the

diseases of aging is the reduced and changing hormonal production and

profile. This is an area that needs some serious research, especially in

this age of Baby Boomers increasing in numbers. We have a healthcare

problem of incredible proportion and hormonal profiling appears to offer

some serious benefits. You would be hard pressed to find any major disease

that is not related to hormone deficiency, or profile.

And this too needs to be approached seriously and not too enthusiastically

as a " fountain of youth " without the proper research.

I find it a great challenge to age with various nutritional and training

strategies to maintain health and performance. I think in the future we

will have a better grasp on various methods of maintaining a more youthful

and healthy endocrine profile. The results will hopefully be a reduction in

age related diseases. It is important that the general public is not led

into an association of any employment of these means as cheating or

dangerous when undertaken in a valid medical usage.

My point is to make sure and define USE versus ABUSE.

As well, there is also some discussion linking Steroid " abuse " /use to

suicide. I find that a difficult case to make on its own. I think you

could create a similar case to just being a teenager since they tend to

commit suicide at an ALARMING rate. The real truth is likely somewhere in

between. The answer is likely that the " emotional type " of person who feels

the need to abuse drugs and or steroids is more likely to commit suicide.

Most of them probably also drink coffee, and have other common practices,

and environmental similarities but the correlation is not drawn.

Rant over. . . .

Regards,

Casler

TRI-VECTOR 3-D Training Systems

Century City, CA

-II-----II-

Posted

Hey Tom!

L. Jay Silvester (former discus record holder and Olympic silver medalist)

presented a paper at an NSCA conference about 15 years ago where he did just

what you propose with discus throwers from his throwing days ('60's & '70's).

He found no link between health problems and AA steroid use. I believe he was

working at BYU at the time. Not sure of his present location.

Best wishes!

Dan Wathen, Youngstown (OH) State University, USA.

>

> One of my graduate students is gathering longevity data on athletes who threw

the discus, shot, and hammer between 1960 and 1985. We are attempting to catalog

the status of the top 25 athletes in each event for those years. Any information

or advice would be appreciated.

>

>

> Tom Fahey

> Dept of Kinesiology

> California State University, Chico

> Chico, CA 95929-0330

>

>

>

>

>

> Re: Anabolic steroids- where are the bodies.

>

> A common refrain amongst apologists for anabolic steroids is : Where are the

>

> bodies? The bodies are in the cemetary ony the death certificated does not

>

> state they died from steroids. The most likely cause of death heart disease.

>

> It might be cardiac arrhythmia or acute MI.

>

> There is an excellent article in the American Journal of Cardiology which

>

> reviews A total of 49 studies describing 1,467 athletes were reviewed to

>

> investigate the cardiovascular effects of the abuse of AAS.

>

> It cites 99 articles covering this topic. If you are interested in this

topic

>

> go to your local hospital Library and check out :

>

> Cardiac and Metabolic Effects of Anabolic-Androgenic Steroid Abuse on Lipids,

>

> Blood Pressure, Left Ventricular Dimensions, and

>

> Rhythm

>

> The American Journal of Cardiology - Volume 106, Issue 6 (September 2010) -

>

> Copyright © 2010 The American College of Cardiology -

>

> Because of copyright and space I cannot put the article here but I have taken

>

> the time to excerpt some of the information I thought might be pertinent along

>

> with the articles or journals cited.

>

> You are not likely to find these studies in your typical muscle magazine or

>

> website. Some of these studies date back to the mid 80s and 90s. The

>

> information is not new just conveniently ignored.

>

> ***********************

>

> Cardiac and Metabolic Effects of Anabolic-Androgenic Steroid Abuse on Lipids,

>

> Blood Pressure, Left Ventricular Dimensions, and Rhythm

>

> The American Journal of Cardiology - Volume 106, Issue 6 (September 2010) -

>

> Copyright © 2010 The American College of Cardiology -

>

> AAS and abnormal plasma lipoproteins

>

> AAS abuse has been linked with abnormal plasma lipoproteins (Table 1). Several

>

> studies suggest that AAS abuse in athletes increase low-density lipoprotein

>

> (LDL)

>

> levels by >20% [14] , [36] , [37] , [38] and decrease high-density lipoprotein

>

> (HDL) levels by 20% to 70%. [13] , [14] , [37] , [39] , [40] , [41] , [42] ,

>

> [43] , [44]

>

> By some estimates, these lipoprotein abnormalities increase

>

> the risk for coronary artery disease by three- to sixfold. [14] , [45]

>

> 13 Sader M.A., Griffiths K.A., McCredie R.J., Handelsman D.J., Celermajer

>

> D.S.: Androgenic anabolic steroids and arterial structure and function in

male

>

> bodybuilders. J Am Coll Cardiol 37. 224-230.2001; Abstract

>

> 14 Lenders J.W., Demacker P.N., Vos J.A., Jansen P.L., Hoitsma A.J., Van't

Laar

>

>

>

> A., Thien T.: Deleterious effects of anabolic steroids on serum lipoproteins,

>

> blood

>

> pressure, and liver function in amateur bodybuilders. Int J Sports Med 9.

>

> 19-23.1988; Abstrac

>

> 36 Lajarin F., Zaragoza R., r I., ez- P.: Evolution of

>

> serum lipids in two male bodybuilders using anabolic steroids. Clin Chem 42.

>

> 970-

>

> 972.1996; Abstract

>

> 37 McKillop G., Ballantyne D.: Lipoprotein analysis in bodybuilders. Int J

>

> Cardiol 17. 281-288.1987; Abstract

>

> 38 Palatini P., Giada F., Garavelli G., Sinisi F., L., Michieletto M.,

>

> Baldo-Enzi G.: Cardiovascular effects of anabolic steroids in weight-trained

>

> subjects. J Clin

>

> Pharmacol 36. 1132-1140.1996; Abstract

>

> 39 Baldo-Enzi G., Giada F., Zuliani G., Baroni L., Vitale E., Enzi G.,

>

> Magnanini P., Fellin R.: Lipid and apoprotein modifications in body builders

>

> during and after self-

>

> administration of anabolic steroids. Metabolism 39. 203-208.1990; Abstract

>

> 40 Fröhlich J., Kullmer T., Urhausen A., Bergmann R., Kindermann W.: Lipid

>

> profile of body builders with and without self-administration of anabolic

>

> steroids. Eur J

>

> Appl Physiol 59. 98-103.1989; 41 Hartgens F., Rietjens G., K

>

> 41 Hartgens F., Rietjens G., Keizer H.A., Kuipers H., Wolffenbuttel B.:

>

> Effects of androgenic-anabolic steroids on apolipoproteins and lipoprotein

(a).

>

> Br J Sport

>

> Med 38. 253-259.2004;

>

> 42 Lane H., Grace F., J.C., K., Cockcroft J., Scanlon M.F.,

Davies

>

>

>

> J.S.: Impaired vasoreactivity in bodybuilders using androgenic anabolic

>

> steroids. Eur J

>

> Clin Invest 36. 483-488.2006; Abstract

>

> 43 Urhausen A., Albers T., Kindermann W.: Are the cardiac effects of

anabolic

>

> steroid abuse in strength athletes reversible?. Heart 90. 496-501.2004;

>

> Abstract

>

> 44 Zuliani U., Bernardini B., Catapano A., Campana M., Cerioli G., Spattini

>

> M.: Effects of anabolic steroids, testosterone, and HGH on blood lipids and

>

> echocardiographic parameteres in body builders. Int J Sports Med 10.

>

> 62-66.1989; Abstract

>

> 45 Glazer G.: Atherogenic effects of anabolic steroids on serum lipid

levels.

>

> A literature reviewArch Intern Med 151. 1925-1933.1991; Abstract

>

> AAS, acute MI, and sudden death

>

> Alarming data have linked AAS with fatal events, although these are mostly

>

> case-control studies and case reports of acute coronary syndromes, MIs, and

>

> ventricular

>

> arrhythmias. [24] , [46] , [83] , [84] , [85] , [86] , [87] , [88]

>

> 88 Fineschi V., Riezzo I., Centini F., Silingardi E., Licata M., Beduschi G.,

>

> Karch S.B.: Sudden cardiac death during anabolic steroid abuse: morphologic

and

>

>

>

> toxicologic findings in two fatal cases of bodybuilders. Int J Legal Med 121.

>

> 48-53.2007; Abstract

>

> 89 Sullivan M.L., ez C.M., Gennis P., Gallagher E.J.: The cardiac

>

> toxicity of anabolic steroids. Prog Cardiovasc Dis 41. 1-15.1998; Abstract

>

> 90 Ferenchick G.: Anabolic/androgenic steroid abuse and thrombosis: is there

a

>

>

>

> connection?. Med Hypotheses 35. 27-31.1991; Abstract

>

> 91 Roeggia M., Heinz G., Werba E., Roeggla G.: Cardiac tamponade in a

>

> 21-year-old body builder with anabolica abuse. Br J Clin Pract 50.

>

> 411-412.1996; Citation

>

> 92 Ferenchick G., Adelman S.: Myocardial infarction associated with anabolic

>

> steroid use in a previously healthy 37-year-old weight lifter. Am Heart J

124.

>

> 507-

>

> 508.1992; Citation

>

> 93 Huie M.: An acute myocardial infarction occurring in an anabolic steroid

>

> user. Med Sci Sport Exer 26. 408-413.1994;

>

> 94 Fisher M., Appleby M., Rittoo D., Cotter L.: Myocardial infarction with

>

> extensive intracoronary thrombus induced by anabolic steroids. Br J Clin

Pract

>

> 50. 222-

>

> 223.1996; Abstract

>

> a postmortem study of male Caucasian AAS abusers (aged 20 to 45 years)

suggested

>

>

>

> primary cardiac pathology in 1/3, [23]

>

> 23 Thiblin I., Lindquist O., Rajs J.: Cause and manner of death among users of

>

> anabolic androgenic steroids. J Forensic Sci 45. 16-23.2000; Abstract

>

> recent case-control study [24] , [25] suggested cardiac causes in 2/3 of

deaths,

>

>

>

> with others being attributed to suicide, hepatic coma, and malignancy.

>

> 24 Parssinen M., Kujala U., Vartiainen E., Sarna S., Seppala T.: Increased

>

> premature mortality of competitive powerlifters suspected to have used

anabolic

>

> agents. Int J Sports Med 21. 225-227.2000; Abstrac

>

> 25 Parssinen M., Seppala T.: Steroid use and long-term health risks in former

>

> athletes. Sports Med 2002. 83-84.2002; 2

>

> Hausmann et al [84] describe a 23-year-old male bodybuilder who abused AAS and

>

> experienced sudden cardiac arrest. Postmortem examination revealed ventricular

>

> hypertrophy, myocardial fibrosis, and acute MI, and the cause of death was

>

> attributed to arrhythmic sudden death secondary to AAS abuse.

>

> 84 Hausmann R., Hammer S., Betz P.: Performance enhancing drugs (doping

agents)

>

> and sudden death†" a case report and review of the literature. Int J Legal Med

>

> 111. 261-264.1998; Abstrac

>

> McNutt et al[46] reported an acute MI in a 22-year-old bodybuilder who

admitted

>

> to AAS abuse but lacked cardiac risk factors. The patient presented with

>

> markedly elevated LDL (596 mg/dl) and depressed HDL (14 mg/dl) yet had no

family

>

>

>

> history of premature atherosclerosis or cardiac events. Within a month of

>

> discontinuing AAS, his LDL decreased to 220 mg/dl and his HDL increased to 35

>

> mg/dl.

>

> 46 McNutt R.A., Ferenchick G.S., Kirlin P.C., Hamlin N.J.: Acute myocardial

>

> infarction in a 22-year-old world class weight lifter using anabolic steroids.

>

> Am J Cardiol62.164.1988; Citation

>

> 49 Bowman S.: Anabolic steroids and infarction. BMJ 300. 750.1990; Citation

>

> Figure 1 shows the presenting electrocardiogram of a 25-year-old male athlete

>

> who abused nandrolone and presented with an acute MI without traditional

cardiac

>

>

>

> risk factors. Acute angiography revealed extensive left anterior descending

>

> coronary artery thrombosis, which was managed by thrombolysis. Angiography in

>

> the subacute phase confirmed very mild luminal irregularity at the site of

>

> previous thrombosis.

>

> 69 Kennedy C.: Myocardial infarction in association with misuse of anabolic

>

> steroids. Ulster Med J 62. 174-176.1993; Citation

>

> The most commonly observed arrhythmias, typically occurring during physical

>

> exertion, include atrial fibrillation, ventricular fibrillation, ventricular

>

> tachycardia, and supraventricular and ventricular ectopic beats. [95]

>

> 95 Furlanello F., Serdoz L.V., Cappato R., De Ambroggi L.: Illicit drugs and

>

> cardiac arrhythmias in athletes. Eur J Cardiovasc Prev Rehabil 14.

487-494.2007;

>

>

>

> Abstract

>

> Dickerman et al [96] reported a 20-year-old male bodybuilder who

>

> self-administered AAS 700 mg/week and had sudden cardiac arrest. Autopsy

>

> indicated LVH with a cardiac mass >2 times the upper limit of normal.

>

> 96 Dickerman R.D., Schaller F., Prather I., McConathy W.J.: Sudden cardiac

death

>

>

>

> in a 20-year-old bodybuilder using anabolic steroids. Cardiology 86.

>

> 172-173.1995; Abstract

>

> ******************

>

> Ralph Giarnella MD

>

> Southington Ct. USA

>

>

Posted

The book, Death In the Locker Room (Bob Goldman 1984) has an introduction from

B. Zeigler M.D. - the man that created the first AAS with Ciba

Pharmaceutical in the mid 50's. In the introduction Zeigler essentially

apologizes for bringing steroids to the US. He saw how quickly AAS use and abuse

became - as he states it - an epidemic among athletes. The man who created the

first American Steroid witnessed first hand the bodies begin to pile up.

On a side not the bibliography of the book alone is nearly 45 pages.

Casey Gallagher CSCS

Snohomish, WA USA

>

> You apparently missed the point of the article. There are numerous case

> studies of young weight lifters and body builders who abused AAS and died

> and subsequently underwent autopsy. These are individuals who had no other

> risk factors for heart disease. When a person dies of heart disease because

> of a bad diet the death certificate does not state that they died because

> they had a poor diet. It just states they died of a heart attack. Death

> certificates do not state that an individual died because of obesity nor

> does it state that they died as the result of smoking. Death certificates

> list the conditions caused by these conditions such as heart diseasea,

> diabetes, emphysema or copd. As a matter of fact in my state (Connecticut)

> only recently has there been a box to check off is smoking might have been a

> contributing cause of this persons death. There is no box to check for

> alcohol abuse, obesity or eating at Mcs. a

>

> There is plenty of science available in the literature concerning the

> dangers of AAS, however the AAS apologists conveninetly ignore the science.

>

> Casler writes:

>

> I think it is extremely important to take an informed viewpoint that looks

> at all the implications. Anabolic Steroids and other endocrine drugs can be

> abused or they can be used. This means don't be an apologist nor an

> alarmist regarding the subject.

>

> We also need to disassociate their medical use with the abuse and cheating

> usage in sports.

>

> While you can draw associations with cases that may have been caused by

> abuse, we should not let that hamper the proper medical use of such

> medications to improve health and the quality of life. There is MUCH

> evidence that the proper medical use will NOT cause heart and coronary

> disease, but it will reduce or prevent it. The hysteria that surrounds

> hormonal abuse is likely warranted, but it need be tempered and disconnected

> from their positive medical implementation.

>

> Insulin is another hormone more commonly used in a medical sense and is

> arguably more anabolic than testosterone. It is also even more dangerous if

> abused or used improperly, so I think we need adapt the same viewpoint to

> all exogenous hormonal use. Broad brush hand waving creates a strange

> phenomenon whereby the " good " that can be done thwarts the amount of

> research that needs to be carried out to be truly helpful.

>

> HRT (hormone replacement therapy) is beginning to gain an interest and it

> would seem that if the " balancing act " of using the medications properly is

> more sophisticated that it will in fact REDUCE cancers, heart disease, sarco

> and osteopenia, diabetes, metabolic syndrome, and many other ailments that

> manifest (especially) males as they suffer a reduction in testosterone

> production.

>

> Enlarged hearts and other heart conditions assigned to steroid abuse may

> certainly be true, but years before steroid abuse was around these same

> conditions fell many former athletes.

>

> I'm just suggesting not to throw the baby out with the bath water. I think

> in the future, if we can get beyond this publicity generated hysteria, so

> that endocrine science will advance and health and the quality of life will

> be enhanced and improved with greater understanding and implementation.

> Just like we now know more about nutrition, and how manipulating our intakes

> can be positive, we will likely see that we can also learn how to control

> hormonal/endocrine levels to a better and healthier result.

>

> Regards,

>

> Casler

> TRI-VECTOR 3-D Training Systems

> Century City, CA

> -II-----II-

>

>

>

>

>

Posted

Dr. Klostergaard is correct about the low dosage taken by throwers from that

time. I published a paper on HDL levels in throwers and weight lifters during

steroid cycles circa 1982 (One athlete had a cholesterol of 320 mg/dL and an HDL

of 12). Their doses were only slightly higher than therapeutic doses, followed

by 4-6 weeks abstinence. Also, few athletes used growth hormone. Still, steroid

researchers warned of premature death, even in those days. We should have data

on 750 throwers in a month or so.

Tom Fahey

Cal State U., Chico

Re: Anabolic steroids- where are the bodies.

All,

Having experienced the AAS world directly as it existed in powerlifting, and

tangentially as it was in the track and field throwing events, from the late

60’s up until the mid-80’s, I would like to ask this discussion to not

overlook

the point made by Dr. Giarnella: supra-physiological.

In my experience, those who used AAS initially, likely a strong majority,

generally kept to doses within or at least close to FDA guidelines, interspersed

with phases of abstinence. Over time, I noticed this practice was gradually

being displaced by reckless dose-escalation, stacking of agents, both oral and

injectable, and a reluctance to “get cleanâ€, even for a brief period of

time.

So while the incidence of drug use during that period (1960-1985) was indeed

likely very high as noted, it was not initially typified by the prevalent

insanity that came later, circa late 70’s and onward: the latter being one of

the major reason I elected to stop use personally, along with the unknowns

regarding use over many years.

Just my $0.02...

Regards and Happy holidays!

======================

Posted

Abuse of anything is a bad thing, by definition, and AAS are no

exception. Still, I am taken aback at the seeming tacit acceptance of

confounding bias in the studies cited here. Studying the results of abuse

of AAS by body-builders and young weight lifters - really? I would be more

interested in almost any other group of AAS abusers; many bodybuilders put

their hearts under incredible stresses by cycling through dangerous levels

of dehydration (among other things - many of which are also related to

cardiac stress/risk). Young weightlifters have the least

experience/guidance/restraint for abuses of any kind, often indulging to the

highest levels.

Tye W. Botting, PhD

Springfield, VA, USA

Join the conversation

You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.

Guest
Reply to this topic...

×   Pasted as rich text.   Paste as plain text instead

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

Loading...
×
×
  • Create New...